Document:

Exhibit 10.1

 

FORM OF

Sixth
Supplement to Amended and Restated Note Purchase Agreement

 

New
Mountain Finance Corporation

 

Dated as of

June 15, 2022

 

To the Purchasers named in

Schedule A hereto

 

Ladies and Gentlemen:

 

This Sixth Supplement to
Amended and Restated Note Purchase Agreement (the “Supplement”) is between New Mountain Finance Corporation, a Delaware
corporation (the “Company”), and the institutional investors named on Schedule A attached hereto (the “Purchasers”).

 

Reference is hereby made
to that certain Amended and Restated Note Purchase Agreement dated September 30, 2016 (the “Note Purchase Agreement”)
among the Company, the First Closing Purchasers listed on Schedule B-1 thereto and the Second Closing Purchasers listed on Schedule B-2
thereto. Except as otherwise provided in sections 4 and 6 below with respect to replacements of “Second Closing Notes,”
 “Second Closing,” “Second Closing Purchaser,” and “Effective Date” all capitalized terms not otherwise
defined herein shall have the same meaning as specified in the Note Purchase Agreement. Reference is further made to Section 4.14
of the Note Purchase Agreement which requires that, prior to the delivery of any Additional Notes, the Company and each Additional Purchaser
shall execute and deliver a Supplement. The Series 2022A Notes (as defined below) constitute Additional Notes under the Note Purchase
Agreement.

 

The Company hereby agrees
with the Purchasers as follows:

 

1.            The
Company has authorized the issue and sale of $75,000,000 aggregate principal amount of its 5.90% Series 2022A Senior Notes due June 15,
2027 (the “Series 2022A Notes”). The Series 2022A Notes, together with the Series 2016 Notes issued
pursuant to the Note Purchase Agreement, the Series 2017A Notes issued pursuant to that certain First Supplement to Amended and
Restated Note Purchase Agreement dated as of June 30, 2017, the Series 2018A Notes issued pursuant to that certain Second Supplement
to Amended and Restated Note Purchase Agreement dated as of January 30, 2018, the Series 2018B Notes issued pursuant to that
certain Third Supplement to Amended and Restated Note Purchase Agreement dated as of July 5, 2018, the Series 2019A Notes issued
pursuant to that certain Fourth Supplement to Amended and Restated Note Purchase Agreement dated as of April 30, 2019, the Series 2021A
Notes issued pursuant to that certain Fifth Supplement to Amended and Restated Note Purchase Agreement dated as of January 29, 2021
and each series of Additional Notes which may from time to time hereafter be issued pursuant to the provisions of Section 2.2 of
the Note Purchase Agreement, are collectively referred to as the “Notes” (such term shall also include any such notes
issued in substitution therefor pursuant to Section 13 of the Note Purchase Agreement). The Series 2022A Notes shall be substantially
in the form set out in Exhibit 1 hereto with such changes therefrom, if any, as may be approved by the Purchasers and the Company.

 

2.            Subject
to the terms and conditions hereof and as set forth in the Note Purchase Agreement and on the basis of the representations and warranties
hereinafter set forth, the Company agrees to issue and sell to each Purchaser, and each Purchaser agrees to purchase from the Company,
Series 2022A Notes in the principal amount set forth opposite such Purchaser’s name on Schedule A hereto at a price of
100% of the principal amount thereof on the Closing Date.

 

     

     

    

 

3.            The
sale and purchase of the Series 2022A Notes to be purchased by each Purchaser shall occur at the offices of Chapman and Cutler LLP,
320 South Canal Street, Chicago, Illinois 60606, at 8:00 a.m. Chicago time, at a closing (the “Closing”)
on June 15, 2022 (the “Closing Date”). At the Closing, the Company will deliver to each Purchaser the Series 2022A
Notes to be purchased by such Purchaser in the form of a single Series 2022A Note (or such greater number of Series 2022A Notes
in denominations of at least $100,000 as such Purchaser may request) dated the date of the Closing and registered in such Purchaser’s
name (or in the name of such Purchaser’s nominee), against delivery by such Purchaser to the Company or its order of immediately
available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for the account of the Company
to account number XXXXXXXXX at U.S. Bank National Association, in Boston, MA, ABA No. XXXXXXXXX.
 If, at the Closing, the Company shall fail to tender such Series 2022A Notes to any Purchaser as provided above in this
Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to such Purchaser’s satisfaction,
such Purchaser shall, at such Purchaser’s election, be relieved of all further obligations under this Agreement, without thereby
waiving any rights such Purchaser may have by reason of such failure or such nonfulfillment.

 

4.            The
Company represents and warrants to each Purchaser, as of the Closing Date, (or, if any such representations and warranties expressly
relate to an earlier date, then as of such earlier date), each of the matters set forth in Section 5 of the Note Purchase Agreement,
as specified subsections of such Section 5 have been supplemented, amended or superseded as set forth on Exhibit A hereto.
The obligation of each Purchaser to purchase and pay for the Series 2022A Notes to be sold to such Purchaser at the Closing is subject
to the fulfillment to such Purchaser’s satisfaction, prior to or at the Closing, of (i) the conditions set forth in Section 4
of the Note Purchase Agreement with respect to the Series 2022A Notes to be purchased at the Closing as if each reference to “Second
Closing Notes,” “Second Closing,” “Second Closing Purchaser,” “Effective Date,” “Schedule
B-2,” and “Schedule 5.5” set forth therein was replaced by “Series 2022A Notes,” the “Closing,”
the “Purchaser,” the “Closing Date,” “Schedule A,” and “Schedule 5.5C” (each
as defined in or attached to this Supplement), respectively, and except to the extent such conditions set forth in Section 4 of
the Note Purchase Agreement are supplemented, amended or superseded hereby, and (ii) the following additional conditions:

 

(a)            Except
as supplemented, amended or superseded by the representations and warranties set forth in Exhibit A hereto, each of the representations
and warranties of the Company set forth in Section 5 of the Note Purchase Agreement shall be correct as of the date of Closing (except
for representations and warranties which apply to a specific earlier date which shall be true as of such earlier date or as of the date
specified in Exhibit A to the extent such provision is superseded in Exhibit A) and the Company shall have delivered to each
Purchaser an Officer’s Certificate, dated the date of the Closing certifying that such condition has been fulfilled.

 

(b)            Contemporaneously
with the Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase, the Series 2022A Notes to be purchased
by such Purchaser at the Closing as specified in Schedule A.

 

    -2-

     

    

 

(c)            Section 4.11
of the Note Purchase Agreement with respect to the Series 2022A Notes shall be amended in its entirety to read as follows:

 

“Section 4.11. Rating.
On the date of the Closing, the Series 2022A Notes shall be rated “BBB-” or better by Fitch Ratings, Inc.”

 

5.            The
terms of Section 8 of the Note Purchase Agreement shall apply to the Series 2022A Notes except that the proviso in the first
sentence of Section 8.2 of the Note Purchase Agreement shall be amended in its entirety to read as follows:

 

“provided, that at any time
on or after February 15, 2021 the Company may, at its option, upon notice as provided below, prepay all or any part of the Series 2016
Notes at 100% of the principal amount so prepaid, together with, in each case, accrued interest to the prepayment date; provided,
further, that at any time on or after April 15, 2022 the Company may, at its option, upon notice as provided below, prepay all
or any part of the Series 2017A Notes at 100% of the principal amount so prepaid, together with, in each case, accrued interest
to the prepayment date; provided, further, that at any time on or after October 30, 2022 the Company may, at its option,
upon notice as provided below, prepay all or any part of the Series 2018A Notes at 100% of the principal amount so prepaid, together
with, in each case, accrued interest to the prepayment date; provided, further, that at any time on or after March 28, 2023,
the Company may, at its option, upon notice as provided below, prepay all or any part of the Series 2018B Notes at 100% of the principal
amount so prepaid, together with, in each case, accrued interest to the prepayment date; provided, further, that at any time on
or after January 30, 2024 the Company may, at its option, upon notice as provided below, prepay all or any part of the Series 2019A
Notes at 100% of the principal amount so prepaid, together with, in each case, accrued interest to the prepayment date; provided,
further, that at any time on or after July 29, 2025 the Company may, at its option, upon notice as provided below, prepay all
or any part of the Series 2021A Notes at 100% of the principal amount so prepaid, together with, in each case, accrued interest
to the prepayment date; provided, further, that at any time on or after December 15, 2026 the Company may, at its option,
upon notice as provided below, prepay all or any part of the Series 2022A Notes at 100% of the principal amount so prepaid, together
with, in each case, accrued interest to the prepayment date.”

 

For the avoidance of doubt,
the definition of “Make-Whole Amount” set forth in Section 8.6 of the Note Purchase Agreement shall be applicable
to any Series 2022A Note.

 

    -3-

     

    

 

6.            Each
Purchaser represents and warrants that the representations and warranties set forth in Section 6 of the Note Purchase Agreement
are true and correct on the date hereof with respect to the purchase of the Series 2022A Notes by such Purchaser as if each reference
to “Second Closing Notes,” “Second Closing” and “Second Closing Purchaser” set forth therein was
replaced by “Series 2022A Notes,” the “Closing” and the “Purchaser,” respectively, and each
reference to “this Agreement” therein was modified to refer to the Note Purchase Agreement as supplemented by this Supplement.

 

Each Purchaser further represents
and warrants that such Purchaser:

 

(a)            is
an “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act and
a Qualified Institutional Buyer; and

 

(b)            has
reviewed the Disclosure Documents and has been furnished with all other materials that it considers relevant to a purchase of the Series 2022A
Notes, has had a full opportunity to ask questions of and receive answers from the Company or any person or persons acting on behalf
of the Company concerning the terms and conditions of a purchase of the Series 2022A Notes and no statement or printed material
which is contrary to the Disclosure Documents has been made or given to the purchaser by or on behalf of the Company; and

 

(c)            is
not relying upon, and has not relied upon, any statement, representation or warranty made by any person, including, without limitation,
Deutsche Bank Securities Inc., any of its affiliates or any of its or their control persons, officers, directors or employees, except
for the statements, representations and warranties contained in the Note Purchase Agreement (as supplemented, amended or superseded hereby)
and the other Disclosure Documents, in making its decision to purchase the Series 2022A Notes.

 

7.            The
Company and each Purchaser agree to be bound by and comply with the terms and provisions of the Note Purchase Agreement (except as supplemented,
amended or superseded hereby) as fully and completely as if such Purchaser were an original signatory to the Note Purchase Agreement.

 

8.            Covenants
of the Company. In addition to the covenants and agreements set forth in the Agreement, the Company covenants and agrees,
which covenants and agreements shall have the benefit of Section 11(c) of the Note Purchase Agreement, for
the benefit of the Purchasers and each other holder of a Note that:

 

(a)            Debt
to Equity Ratio. Immediately after the issuance of any senior security representing indebtedness (as determined pursuant to the Investment
Company Act), and after giving pro forma effect thereto and the application of the proceeds thereof, the Company will not permit the
Debt to Equity Ratio, to be greater than 1.65 to 1.00.

 

    -4-

     

    

 

“Debt to Equity Ratio”
means the ratio of (a) the aggregate amount of senior securities representing indebtedness of the Company and its Subsidiaries
(including under the Notes), in each case as determined pursuant to the Investment Company Act, and any orders of the SEC issued to or
with respect to Company thereunder, including any exemptive relief granted by the SEC with respect to the indebtedness of any SBIC Subsidiary
to (b) Shareholders’ Equity at the last day of the immediately preceding fiscal quarter of the Company.

 

(b)            Maximum
Secured Debt. The Company will not permit the Secured Debt Ratio at any time to exceed 0.70 to 1.00.

 

“Secured Debt” means
Indebtedness of the Company and its Subsidiaries that are consolidated with the Company for purposes of GAAP (excluding any Indebtedness
of any of the Company’s Subsidiaries which are SBIC Subsidiaries) outstanding at any time that is secured in any manner by any
Lien on assets of the Company or any such Subsidiaries.

 

“Secured Debt Ratio”
means the ratio of (a) Secured Debt to (b) the aggregate amount of Indebtedness of the Company and its Subsidiaries that are
consolidated with the Company for purposes of GAAP (including Indebtedness under the Notes and excluding any Indebtedness of any of the
Company’s Subsidiaries which are SBIC Subsidiaries).

 

9.            Covenants
of the Company. The Company covenants and agrees, for the benefit of the Purchasers and each other holder of a Note, that for the
avoidance of doubt and for purposes of determining the Asset Coverage Ratio and the Debt to Equity Ratio, “the aggregate amount
of senior securities representing indebtedness of the Company and its Subsidiaries” shall be deemed to include the obligations
of the Company under any Permitted SBIC Guaranty for any period after the occurrence of an event or condition that is an impermissible
change in the control of the applicable SBIC Subsidiary as a result of which the Permitted SBIC Guaranty permits recourse to the Company
as permitted pursuant to the definition of “Permitted SBIC Guaranty.”

 

10.            Ratings
Covenant of the Company. In addition to the covenants and agreements set forth in the Note Purchase Agreement and this Supplement,
the Company covenants and agrees for the benefit of the Purchasers and each other holder of a Note that, to the extent the Company shall
maintain or deliver, in accordance with the Note Purchase Agreement, a Rating, such Rating shall be a public rating, issued by a NRSRO,
of the Notes and, with respect to the Series 2022A Notes, shall specifically describe the Series 2022A Notes, including their
interest rate, maturity and Private Placement Number.

 

    -5-

     

    

 

11.            Events
of Default of the Company. In addition to the covenants, agreements and Events of Default set forth in the Note Purchase Agreement
and this Supplement, the Company covenants and agrees for the benefit of the Purchasers and each other holder of a Note that, in addition
to the defaults or conditions under any Material Indebtedness of the Company and its Significant Subsidiaries that constitute an Event
of Default under Section 11(f) of the Note Purchase Agreement, any such defaults or conditions, as specified in Section 11(f) of
the Note Purchase Agreement, under any Material Indebtedness of the Company’s Subsidiaries that are consolidated with the Company
for purposes of GAAP (excluding any Indebtedness of any of the Company’s Subsidiaries which are SBIC Subsidiaries) shall also constitute
an Event of Default under Section 11(f) of the Note Purchase Agreement.

 

12.            Definitions.
In addition to the covenants, agreements and Events of Default set forth in the Note Purchase Agreement and this Supplement, the Company
covenants and agrees for the benefit of the Purchasers and each other holder of a Note that the: (a) definitions of “Canada
Blocked Person” and “Canadian Economic Sanctions Laws” shall be amended in their entirety to read as follows:

 

“Canada Blocked
Person” means (i) a “terrorist group” as defined for the purposes of Part II.1 of the Criminal Code (Canada),
as amended or (ii) a Person identified in or pursuant to (w) Part II.1 of the Criminal Code (Canada), as amended or (x) the
Proceeds of Crime (Money Laundering) and Terrorist Financing Act, as amended or (y) the Justice for Victims of Corrupt Foreign Officials
Act (Sergei Magnitsky Law), as amended or (z) regulations or orders promulgated pursuant to the Special Economic Measures Act (Canada),
as amended, the United Nations Act (Canada), as amended, or the Freezing Assets of Corrupt Foreign Officials Act (Canada), as amended,
in any case pursuant to this clause (ii) as a Person in respect of whose property or benefit a holder of Notes would be prohibited
from entering into or facilitating a related financial transaction.

 

“Canadian Economic
Sanctions Laws” means those laws, including enabling legislation, orders-in-council or other regulations administered and enforced
by Canada or a political subdivision of Canada pursuant to which economic sanctions have been imposed on any Person, entity, organization,
country or regime, including Part II.1 of the Criminal Code (Canada), as amended, the Special Economic Measures Act (Canada), as
amended, the Proceeds of Crime (Money Laundering) and Terrorist Financing Act, as amended, the Justice for Victims of Corrupt Foreign
Officials Act (Sergei Magnitsky Law), as amended, the United Nations Act (Canada), as amended, the Export and Import Permits Act (Canada),
as amended, and the Freezing Assets of Corrupt Foreign Officials Act (Canada), as amended, and including all regulations promulgated
under any of the foregoing, or any other similar sanctions program or action.

 

    -6-

     

    

 

The execution hereof shall
constitute a contract between the Company and the Purchasers for the uses and purposes hereinabove set forth, and this agreement may
be executed in any number of counterparts, each executed counterpart constituting an original but all together only one agreement.

 

	 	New Mountain Finance Corporation
	 	 
	 	 
	 	By	 
	 	 	Name: 	Shiraz Y. Kajee
	 	 	Title: 	Chief Financial Officer

 

    New Mountain Finance Corporation
Sixth Supplement to Amended and Restated Note Purchase Agreement

     

    

 

This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

		[Purchasers] 
	 	 
		By:	                                       ,
	 	 	its investment manager

 

	 		By	 
	 		 	Name:	
	 		 	Title:	

 

    New Mountain Finance Corporation
Sixth Supplement to Amended and Restated Note Purchase Agreement

     

    

 

Supplemental
Representations

 

The Company represents and
warrants to each Purchaser that except as hereinafter set forth in this Exhibit A, each of the representations and warranties set
forth in Section 5 of the Note Purchase Agreement (other than representations and warranties that apply solely to a specific earlier
date which shall be true as of such earlier date) is true and correct in all material respects as of the date hereof with respect to
the Series 2022A Notes with the same force and effect as if each reference to “the Second Closing Notes” set forth therein
was modified to refer to the “Series 2022A Notes” and each reference to “this Agreement” therein was modified
to refer to the Note Purchase Agreement as supplemented by the Sixth Supplement. The Section references hereinafter set forth correspond
to the similar sections of the Note Purchase Agreement which are supplemented hereby:

 

Section 5.3.     Disclosure.
(a) The Company, through its agent, Deutsche Bank Securities Inc., has delivered to each Purchaser a copy of the documents, certificates
or other writings identified in Schedule 5.3C and has made publicly available via the SEC’s EDGAR filing system its quarterly
and annual reports on Form 10-Q and Form 10-K, respectively, including the Company’s annual report on Form 10-K
for the fiscal year ended December 31, 2021 (the “Initial Disclosure Materials”), relating to the transactions
contemplated hereby. The Initial Disclosure Materials fairly describe, in all material respects, the general nature of the business and
principal properties of the Company and its Subsidiaries. This Agreement, the Initial Disclosure Materials, the financial statements
listed in Schedule 5.5C and the documents, certificates or other writings delivered to the Purchasers by or on behalf of the Company
(other than financial projections, pro forma financial information, and other forward-looking information referenced in Section 5.3(b))
on or prior to May 9, 2022 in connection with the transactions contemplated hereby and identified in Schedule 5.3C (this Agreement,
the Initial Disclosure Materials and such documents, certificates or other writings, including, without limitation, valuations of Investments
of the Company, and such financial statements delivered to each Purchaser (other than financial projections, pro forma financial information,
and other forward-looking information referenced in Section 5.3(b)) being referred to, collectively, as the “Disclosure
Documents”), taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary
to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the Disclosure
Documents, since December 31, 2021, there has been no change in the financial condition, operations, business, properties or prospects
of the Company or any Subsidiary except changes that could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not
been set forth herein or in the Disclosure Documents.

 

(b)            All
financial projections, pro forma financial information and other forward-looking information which has been delivered to each Purchaser
by or on behalf of the Company in connection with the transactions contemplated by this Agreement are based upon good faith assumptions
and, in the case of financial projections and pro forma financial information, good faith estimates, in each case, believed to be reasonable
at the time made, it being recognized that (i) such financial information as it relates to future events is subject to significant
uncertainty and contingencies (many of which are beyond the control of the Company) and are therefore not to be viewed as fact, and (ii) actual
results during the period or periods covered by such financial information may materially differ from the results set forth therein.

 

Exhibit A

(to Sixth Supplement)

 

     

     

    

 

Section 5.4.     Organization
and Ownership of Shares of Subsidiaries; Affiliates. (a) Schedule 5.4C contains (except
as noted therein) complete and correct lists of (i) the Company’s Subsidiaries, showing, as to each Subsidiary, the name thereof,
the jurisdiction of its organization, and the percentage of shares of each class of its capital stock or similar equity interests outstanding
owned by the Company and each other Subsidiary, (ii) the Company’s Affiliates, other than Subsidiaries, and (iii) the
Company’s directors and senior officers.

 

(b)            All
of the outstanding shares of capital stock or similar equity interests of each Subsidiary shown in Schedule 5.4C as being owned
by the Company and its Subsidiaries have been validly issued, are fully paid and non-assessable and are owned by the Company or another
Subsidiary free and clear of any Lien that is prohibited by this Agreement.

 

(d)            No
Subsidiary is subject to any legal, regulatory, contractual or other restriction (other than the agreements listed on Schedule 5.4C
and customary limitations imposed by corporate law or similar statutes) restricting the ability of such Subsidiary to pay dividends out
of profits or make any other similar distributions of profits to the Company or to any other Subsidiary of the Company that owns outstanding
shares of capital stock or similar equity interests of such Subsidiary.

 

Section 5.5.     Financial
Statements; Material Liabilities. The Company has delivered to each Purchaser or made publicly
available via the SEC’s EDGAR filing system copies of the financial statements of the Company and its Subsidiaries listed on Schedule 5.5C.
All of such financial statements (including in each case the related schedules and notes) fairly present in all material respects the
consolidated financial position of the Company and its Subsidiaries as of the respective dates specified in such Schedule and the consolidated
results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP consistently
applied throughout the periods involved except as set forth in the notes thereto (subject, in the case of any interim financial statements,
to normal year-end adjustments). The Company and its Subsidiaries do not have any Material liabilities that are not disclosed in the
Disclosure Documents.

 

Section 5.13.     Private
Offering by the Company. Neither the Company nor anyone acting on its behalf has offered the
Series 2022A Notes or any similar Securities (other than any Notes previously issued pursuant to the Note Purchase Agreement and
identified on Schedule 5.15C) for sale to, or solicited any offer to buy the Series 2022A Notes or any similar Securities (other
than any Notes previously issued pursuant to the Note Purchase Agreement and identified on Schedule 5.15C) from, or otherwise approached
or negotiated in respect thereof with, any Person other than not more than twenty-five (25) Institutional Investors and the Purchasers,
each of which has been offered the Series 2022A Notes at a private sale for investment. Neither the Company nor anyone acting on
its behalf has taken, or will take, any action that would subject the issuance or sale of the Series 2022A Notes to the registration
requirements of section 5 of the Securities Act or to the registration requirements of any Securities or blue sky laws of any applicable
jurisdiction.

 

    -2-

     

    

 

Section 5.14.     Use
of Proceeds; Margin Regulations. The Company will apply the proceeds of the sale of the Series 2022A
Notes to repay outstanding Indebtedness of the Company and its Subsidiaries and/or for other general corporate purposes of the Company,
including the acquisition and funding (either directly or through one or more wholly-owned Subsidiaries) of leveraged loans, mezzanine
loans, high-yield securities, convertible securities, preferred stock, common stock, and other Portfolio Investments. No part of the
proceeds from the sale of the Series 2022A Notes hereunder will be used, directly or indirectly, for the purpose of buying or carrying
any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for
the purpose of buying or carrying or trading in any Securities under such circumstances as to involve the Company in a violation of Regulation X
of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin
stock does not constitute more than 10% of the value of the consolidated assets of the Company and the Company does not have any present
intention that margin stock will constitute more than 10% of the value of such assets. As used in this Section, the terms “margin
stock” and “purpose of buying or carrying” shall have the meanings assigned to them in said Regulation U.

 

Section 5.15.     Existing
Indebtedness; Future Liens. (a) Except as described therein, Schedule 5.15C sets forth
a complete and correct list of all outstanding Indebtedness of the Company and its Subsidiaries as of March 31, 2022 (including
descriptions of the obligors and obligees, principal amounts outstanding, any collateral therefor and any Guaranties thereof), since
which date there has been no Material change in the amounts, interest rates, sinking funds, installment payments or maturities of the
Indebtedness of the Company or its Subsidiaries. Neither the Company nor any Subsidiary is in default and no waiver of default is currently
in effect, in the payment of any principal or interest on any Indebtedness of the Company or such Subsidiary and no event or condition
exists with respect to any Indebtedness of the Company or any Subsidiary that would permit (or that with notice or the lapse of time,
or both, would permit) one or more Persons to cause such Indebtedness to become due and payable before its stated maturity or before
its regularly scheduled dates of payment.

 

(b)            Except
as disclosed in Schedule 5.15C, neither the Company nor any Subsidiary has agreed or consented to cause or permit any of its property,
whether now owned or hereafter acquired, to be subject to a Lien that secures Indebtedness or to cause or permit in the future (upon
the happening of a contingency or otherwise) any of its property, whether now owned or hereafter acquired, to be subject to a Lien that
secures Indebtedness.

 

(c)            Neither
the Company nor any Subsidiary is a party to, or otherwise subject to any provision contained in, any instrument evidencing Indebtedness
of the Company or such Subsidiary, any agreement relating thereto or any other agreement (including, but not limited to, its charter
or any other organizational document) which limits the amount of, or otherwise imposes restrictions on the incurring of, Indebtedness
of the Company, except as disclosed in Schedule 5.15C.

 

    -3-

     

    

 

[Form of
Series 2022A Note]

 

New
Mountain Finance Corporation

 

5.90%
Series 2022A Senior Note due June 15, 2027

 

	No. [_________]	[Date]
	$[____________]	PPN 647551 C@7

 

For
Value Received, the undersigned, New Mountain Finance Corporation (herein called
the “Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay
to [____________], or registered assigns, the principal sum of [_____________________] Dollars
(or so much thereof as shall not have been prepaid) on June 15, 2027 (the “Maturity Date”), with interest
(computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of (a) subject
to adjustment pursuant to Section 1.2 of the hereinafter defined Note Purchase Agreement, 5.90% per annum from the date hereof,
payable semiannually, on the 15th day of June and December in each year, commencing December 15, 2022, and on the Maturity
Date, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, (x) on any overdue
payment of interest and (y) during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of
any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate (as defined in the hereinafter defined Note Purchase
Agreement).

 

Payments of principal of,
interest on and any Make-Whole Amount with respect to this Note are to be made in lawful money of the United States of America at Wells
Fargo Bank, National Association at its offices in New York, New York or at such other place as the Company shall have designated
by written notice to the holder of this Note as provided in the Note Purchase Agreement referred to below.

 

This Note is one of a series
of Senior Notes (the “Notes”) issued pursuant to a Supplement to the Amended and Restated Note Purchase Agreement
dated September 30, 2016 (as from time to time amended, supplemented or modified, the “Note Purchase Agreement”),
among the Company, the First Closing Purchasers and the Second Closing Purchasers named therein and Additional Purchasers of Notes from
time to time issued pursuant to any Supplement to the Note Purchase Agreement. This Note and the holder hereof are entitled equally and
ratably with the holders of all other Notes of all series from time to time outstanding under the Note Purchase Agreement to all the
benefits provided for thereby or referred to therein. Each holder of this Note will be deemed, by its acceptance hereof, (i) to
have agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and (ii) to have made
the representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in
this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement.

 

This Note is a registered
Note with the Company and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration of transfer accompanied
by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in
writing, a new Note of the same series for a like principal amount will be issued to, and registered in the name of, the transferee.
Prior to due presentment for registration of transfer, the Company may treat the Person in whose name this Note is registered and is
recorded in the register as the owner hereof for the purpose of receiving payment and for all other purposes, and the Company will not
be affected by any notice to the contrary.

 

Exhibit 1

(to Sixth Supplement)

 

     

     

    

  

This Note is subject to optional
prepayment, and mandatory and optional offers of prepayment, in whole or from time to time in part, at the times and on the terms specified
in the Note Purchase Agreement, but not otherwise.

 

If an Event of Default occurs
and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including
any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement.

 

This Note shall be construed
and enforced in accordance with, and the rights of the Company and the holder of this Note shall be governed by, the law of the State
of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction
other than such State.

 

	 	New Mountain Finance Corporation
	 	 
	 	 
	 	By	 
	 	 	Name: 	Shiraz Y. Kajee
	 	 	Title: 	Chief Financial Officer

 

    -2-Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT
(this “Subscription Agreement”) is entered into on June [●], 2022, by and between JATT Acquisition Corp, a Cayman
Islands exempted company (the “Company”), and the subscriber named on the signature page hereto (“Subscriber”).

 

WHEREAS, pursuant to, and
upon the terms and subject to the conditions set forth in, the Business Combination Agreement dated on or after the date of this Subscription
Agreement (the “Business Combination Agreement”), among the Company, JATT Merger Sub, a Cayman Islands exempted company
and wholly owned subsidiary of the Company (“JATT Merger Sub”), JATT Merger Sub 2, a Cayman Islands exempted company
and wholly owned subsidiary of the Company (“JATT Merger Sub 2”), Zura Bio Limited, a limited company incorporated
under the laws of England and Wales (“Zura”) and Zura Bio Holdings Ltd, a Cayman Islands exempted company (“Zura
Holdco”), the following transactions (collectively, the “Transaction”) will occur on the Closing Date (as
defined below): (i) JATT Merger Sub will merge with and into Zura Holdco, with Zura Holdco continuing as the surviving company of the
merger and a wholly owned subsidiary of the Company; and (ii) immediately following the transaction described in (i), Zura Holdco will
merge with and into JATT Merger Sub 2, with JATT Merger Sub 2 continuing as the surviving company of the merger;

 

WHEREAS, in connection with
the Transaction, Subscriber desires to subscribe for and purchase from the Company, immediately prior to or substantially concurrently
with, and contingent upon, the consummation of the Transaction, that number of ordinary shares (“Ordinary Shares”),
set forth on the signature page hereto (the “Subscribed Shares”) and that number of private placement warrants of the
Company as shown on Exhibit A under the column “Subscribed Amount New PIPE Subscriber Prorated Share of PPWs” attached
hereto and made a part hereof, each whole warrant entitling the holder thereof to purchase one Ordinary Share for $11.50 per share (the
 “Private Placement Warrants”) for a purchase price of $10.00 per share (the “Per Unit Subscription Price”
and the aggregate of such Per Unit Subscription Price for all Subscribed Shares and Private Placement Warrants being referred to herein
as the “Subscription Amount”), and the Company desires to issue and sell to Subscriber the Subscribed Shares and Private
Placement Warrants in consideration of the payment of the Subscription Amount by or on behalf of Subscriber to the Company; and

 

WHEREAS, substantially concurrently
with the execution of this Subscription Agreement, the Company will enter into subscription agreements (the “Other Subscription
Agreements” and, together with this Subscription Agreement, the “Subscription Agreements”) with certain other
accredited investors (the “Other Subscribers” and, together with Subscriber, the “Subscribers”),
which are on substantially the same terms as the terms of this Subscription Agreement (other than the amount of Ordinary Shares and Private
Placement Warrants to be subscribed for and purchased by the Other Subscribers), pursuant to which such investors shall agree to purchase
on the closing date of the Transaction (the “Closing Date”) Ordinary Shares (the “Other Subscribed Shares”
and, together with the Subscribed Shares, the “Aggregate Subscribed Shares”) and Private Placement Warrants (the “Other
Private Placement Warrants” and, together with the Private Placement Warrants, the “Aggregate Private Placement Warrants”)
for aggregate subscription amounts, together with the Subscription Amount, of not less than $20 million.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending
to be legally bound hereby, the parties hereto hereby agree as follows:

 

1.               
Subscription. Subject to the terms and conditions hereof, Subscriber hereby subscribes for and agrees to purchase at the
Closing (as defined below), and the Company hereby agrees to issue and sell to Subscriber, upon the payment of the Subscription Amount,
the Subscribed Shares and the Private Placement Warrants (such subscription and issuance, the “Subscription”). The
Company hereby expressly covenants and agrees that the Subscription Amount shall be used exclusively for the Transaction or after the
consummation thereof by the Company and its subsidiaries (including Zura) for working capital and other corporate purposes.

 

     

     

    

 

2.               
Closing.

 

(a)             
The consummation of the Subscription (the “Closing”) shall be contingent upon, and occur on the Closing Date immediately
prior to or concurrently with the consummation of the Transaction.

 

(b)             
At least five Business Days before the anticipated Closing Date, the Company shall deliver written notice to Subscriber (the “Closing
Notice”) specifying (i) the anticipated Closing Date and (ii) the wire instructions for delivery of the Subscription Amount
to the Company. No later than three Business Days after receiving the Closing Notice, Subscriber shall deliver to the Company such information
as is reasonably requested in the Closing Notice in order for the Company to issue the Subscribed Shares and Private Placement Warrants
to Subscriber. Subscriber shall two (2) business days prior to the expected Closing Date specified in the Closing Notice, deliver to the
Company, the Subscription Amount in cash via wire transfer to the account specified in the Closing Notice. At the Closing, the Company
shall issue the Subscribed Shares and Private Placement Warrants to the Subscriber and cause the Subscribed Shares and Private Placement
Warrants to be registered in book entry form, free and clear of any liens or other restrictions (other than those arising under this Subscription
Agreement or state or federal securities laws), in the name of Subscriber (or its nominee in accordance with its delivery instructions)
or to a custodian designated by Subscriber, as applicable. In the event that the consummation of the Transaction does not occur within
three Business Days after the anticipated Closing Date specified in the Closing Notice, the Company shall promptly (but in no event later
than three Business Days after the anticipated Closing Date specified in the Closing Notice) return the funds so delivered by Subscriber
to the Company by wire transfer in immediately available funds to the account specified by Subscriber; provided that, unless this Subscription
Agreement has been validly terminated pursuant to Section 6 hereof, neither the failure of the Closing to occur on the Closing
Date specified in the Closing Notice nor such return of funds shall (x) terminate this Subscription Agreement, (y) be deemed to be
a failure of any of the conditions to Closing set forth in this Section 2, or (z) otherwise relieve any party of any of its obligations
hereunder, including Subscriber’s obligation to redeliver the Subscription Amount and purchase the Subscribed Shares and Private
Placement Warrants at the Closing in the event the Company delivers a subsequent Closing Notice. For the purposes of this Subscription
Agreement, “Business Day” means any day other than a Saturday, Sunday or a day on which the Federal Reserve Bank of
New York is closed. Prior to or at the Closing, Subscriber shall deliver to the Company a duly completed and executed Internal Revenue
Service Form W-9 or appropriate Form W-8.

 

(c)             
The Closing shall be subject to the satisfaction or valid waiver (to the extent a valid waiver is capable of being issued) by the party
(the Company, on the one hand, or Subscriber, on the other) entitled to the benefit thereof, of the conditions that, on or prior to the
Closing Date:

 

(i)              
the Ordinary Shares shall have been approved for listing on the New York Stock Exchange (the “NYSE”), subject to official
notice of issuance, and no suspension of the qualification of the Ordinary Shares for offering or sale or trading on NYSE, or, to the
Company’s knowledge, initiation or threatening of any proceedings for any of such purposes, shall have occurred;

 

(ii)             
all conditions precedent to the closing of the Transaction set forth in the Business Combination Agreement, including, without
limitation, the required approval of the Company’s shareholders, shall have been satisfied (as determined by the parties to
the Business Combination Agreement, and other than those conditions which, by their nature, are to be satisfied at the closing of
the Transaction, but subject to satisfaction or waiver thereof by the party entitled to the benefit thereof under the Business
Combination Agreement, including to the extent that any such condition is dependent upon the consummation of the purchase and sale
of the Aggregate Subscribed Shares and Aggregate Private Placement Warrants pursuant to the Subscription Agreements) or waived in
writing by the party entitled to the benefit thereof under the Business Combination Agreement; and

 

    2

     

    

 

(iii)            
no governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation (whether
temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
hereby illegal or otherwise restraining, prohibiting or enjoining consummation of the transactions contemplated hereby (except in the
case of a governmental authority located outside the United States where such judgment, order, law, rule or regulation would not be reasonably
expected to have a Company Material Adverse Effect (as defined below)).

 

(d)             
The obligation of the Company to consummate the Closing shall be subject to the satisfaction or valid waiver by the Company of the additional
conditions that, on or prior to the Closing Date:

 

(i)              
all representations and warranties of Subscriber contained in this Subscription Agreement are true and correct in all material respects
at and as of the Closing Date (other than (x) representations and warranties that are qualified as to materiality or Subscriber Material
Adverse Effect (as defined below), which representations and warranties shall be true in all respects or (y) representations and warranties
that speak as of a specified earlier date, which representations and warranties shall be true and correct in all material respects (or,
if qualified by materiality or Subscriber Material Adverse Effect, which representations shall be true and correct in all respects) as
of such specified date), in each case without giving effect to the consummation of the Transaction, and consummation of the Closing shall
constitute a reaffirmation by Subscriber of each of the representations and warranties of Subscriber contained in this Subscription Agreement
as of the Closing;

 

(ii)             
Subscriber shall have wired the Subscription Amount in accordance with Section 2(b) of this Subscription Agreement and otherwise performed,
satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement
to be performed, satisfied or complied with by it at or prior to the Closing; and

 

(iii)            
Subscriber shall have provided to the Company the information requested in Annex A hereto.

 

(e)             
The obligation of Subscriber to consummate the Closing shall be subject to the satisfaction or valid waiver by Subscriber of the additional
conditions that, on or prior to the Closing Date:

 

(i)              
all representations and warranties of the Company contained in this Subscription Agreement are true and correct in all material
respects at and as of the Closing Date (other than (A) representations and warranties that are qualified as to materiality or
Company Material Adverse Effect (as defined below), which representations and warranties shall be true in all respects or (B)
representations and warranties that speak as of a specified earlier date, which representations and warranties shall be true and
correct in all material respects (or, if qualified by materiality or Company Material Adverse Effect, which representations shall be
true and correct in all respects) as of such specified date), in each case without giving effect to the consummation of the
Transaction, and consummation of the Closing shall constitute a reaffirmation by the Company of each of the representations and
warranties of the Company contained in this Subscription Agreement as of the Closing; provided that in the event this condition
would otherwise fail to be satisfied as a result of a breach of one or more of the representations and warranties of the Company
contained in this Subscription Agreement and the facts underlying such breach would also cause a condition to Zura’s
obligations under the Business Combination Agreement to fail to be satisfied, this condition shall nevertheless be deemed satisfied
in the event Zura waives such condition with respect to such breach under the Business Combination Agreement;

 

    3

     

    

 

(ii)             
the Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing, except where the failure
of such performance, satisfaction or compliance would not or would not reasonably be expected to materially and adversely affect the economic
benefits to Subscriber under this Subscription Agreement; and

 

(iii)            
there shall have been no amendment or modification to the Business Combination Agreement that materially, adversely and disproportionately
as compared to Other Subscribers affects the economic benefits to Subscriber under this Subscription Agreement without having received
Subscriber’s prior written consent.

 

3.               
Company Representations and Warranties. For purposes of this Section 3, the term “Company” shall refer
to (i) the Company as of the date hereof, and (ii) for purposes of the representations contained in subsections (f), (i) and (l) of this
Section 3 and to the extent such representations and warranties are made as of the Closing Date, the combined company after giving
effect to the Transaction as of the Closing Date. The Company represents and warrants to Subscriber that as of the date hereof:

 

(a)             
The Company (i) has been duly incorporated and is validly existing as a corporation in good standing under the laws of the Cayman
Islands, (ii) has the requisite corporate power and authority to own, lease and operate its properties, to carry on its business as
it is now being conducted and to enter into and perform its obligations under this Subscription Agreement, and (iii) is duly
licensed or qualified to conduct its business and, if applicable, is in good standing under the laws of each jurisdiction (other
than its jurisdiction of incorporation) in which the conduct of its business or the ownership of its properties or assets requires
such license or qualification, except, with respect to the foregoing clause (iii), where the failure to be in good standing would
not reasonably be expected to have a Company Material Adverse Effect. For purposes of this Subscription Agreement, a
 “Company Material Adverse Effect” means any event, circumstance, change, development, effect or occurrence
(collectively “Effect”) that, individually or in the aggregate with all other Effects, (a) is or would reasonably
be expected to be materially adverse to the business, financial condition or results of operations of the Company and its
subsidiaries, taken as a whole; or (b) would prevent, materially delay or materially impede the performance by the Company or its
subsidiaries of their respective obligations under this Subscription Agreement, the Business Combination Agreement or the
consummation of the Transaction before the Outside Date (as defined below); provided, however, that, in the case of clause (a), none
of the following (or the effect of any of the following) shall be deemed to constitute, alone or in combination, or be taken into
account in the determination of whether, there has been or will be a Company Material Adverse Effect: (i) any change or proposed
change in applicable law or GAAP or IFRS, as applicable (including, in each case, the interpretation thereof) or changes in
enforcement policies or official interpretations thereof or decisions of general applicability by any governmental entity, in each
case, after the date of this Subscription Agreement; (ii) events, changes or conditions generally affecting the industries or
geographic areas in which the Company operates; (iii) any changes in general economic conditions, including changes in the credit,
debt, securities, financial or capital markets (including changes in interest or exchange rates, prices of any security or market
index or commodity or any disruption of such markets); (iv) acts of war, sabotage, civil unrest, protests, demonstrations,
cyberattacks or terrorism, or any escalation or worsening of any such acts of war, sabotage, civil unrest, protests, demonstrations,
cyberattacks or terrorism, or changes in global, national, regional, state or local political or social conditions; (v) any
hurricane, tornado, flood, earthquake, mudslide, wildfire, natural disaster, epidemic, disease outbreak, pandemic (including, for
the avoidance of doubt, the novel coronavirus, SARS-CoV-2 or COVID-19 and all related measures, strains and sequences) or other acts
of God, (vi) any actions taken or not taken by the Company as required by this Subscription Agreement, the Business Combination
Agreement or any other agreement executed and delivered in connection with the Transaction and specifically contemplated by the
Business Combination Agreement, (vii) any failure of Zura and its subsidiaries, taken as a whole to meet any projections, forecasts,
guidance, estimates or financial or operating predictions of revenue, earnings, cash flow or cash position (provided, that any
Effect underlying such failure (except to the extent otherwise excluded by other clauses in this definition) may be taken into
account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur) or (viii)
any Effect attributable to the announcement or execution, pendency, negotiation or consummation of this Subscription Agreement or
the Transaction (including the impact thereof on relationships with customers, suppliers, employees, investors, or other third
parties related thereto), except in the cases of clauses (i) through (v), to the extent that the Company is materially and
disproportionately affected thereby as compared with other participants in the industry in which the Company operates.

 

    4

     

    

 

(b)             
As of the Closing Date, the Subscribed Shares will be duly authorized and, when issued and delivered to Subscriber against full payment
therefor in accordance with the terms of this Subscription Agreement, will be validly issued.

 

(c)             
As of the Closing Date, the Private Placement Warrants will be duly authorized and, when issued and delivered to Subscriber against full
payment therefor in accordance with the terms of this Subscription Agreement, will be enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws affecting
creditors generally and by the availability of equitable remedies..

 

(d)             
The Subscribed Shares and the Private Placement Warrants are not, and following the Closing, will not be, subject to any Transfer Restriction.
The term “Transfer Restriction” means any condition to or restriction on the ability of the undersigned to pledge,
sell, assign or otherwise transfer the Subscribed Shares and Private Placement Warrants under any organizational document, policy or agreement
of, by or with the Company, but excluding (i) the restrictions on transfer described in Section 4(e) of this Subscription Agreement
with respect to the status of the Shares and the Private Placement Warrants as “restricted securities” pending their registration
for resale under the Securities Act of 1933, as amended (the “Securities Act”), in accordance with the terms of this
Subscription Agreement, and (ii) compliance with routine transfer registration provisions under the Company’s organizational documents
and agreements and policies of the Company’s transfer agent.

 

(e)             
This Subscription Agreement has been duly authorized, executed and delivered by the Company, and assuming the due authorization,
execution and delivery of the same by Subscriber, this Subscription Agreement shall constitute the valid and binding obligation of
the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by
bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors generally and by the availability of
equitable remedies.

 

    5

     

    

 

(f)              
The execution and delivery of this Subscription Agreement, the issuance and sale of the Subscribed Shares and the Private Placement Warrants
and the compliance by the Company with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated
herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under,
or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company pursuant
to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the
Company is a party or by which the Company is bound or to which any of the property or assets of the Company is subject; (ii) the
organizational documents of the Company; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental
agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties that, in the case of clauses (i) and
(iii), would reasonably be expected to have a Company Material Adverse Effect.

 

(g)             
Assuming the accuracy of all of Subscriber’s representations and warranties set forth in Section 4 of this Subscription Agreement,
the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection
with the execution, delivery and performance of this Subscription Agreement (including, without limitation, the issuance of the Subscribed
Shares and Private Placement Warrants ), other than (i) filings required by applicable state securities laws, (ii) filings with the United
States Securities and Exchange Commission (the “Commission”), including the filing of the Registration Statement pursuant
to Section 5 below, (iii) filings required by the NYSE, including with respect to obtaining approval of the Company’s shareholders,
(iv) filings required to consummate the Transaction as provided under the Business Combination Agreement, (v) any filing of notification
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or any law or regulation of any other jurisdiction related to competition
or merger control, if applicable, (vi) those that will be obtained, made or given, as applicable, on or prior to the Closing, and (vii)
consents, waivers, authorizations, orders, notices or filings, the failure of which to obtain would not reasonably be expected to have
a Company Material Adverse Effect or have a material adverse effect on the Company’s legal authority to consummate the transactions
contemplated hereby, including the issuance and sale of the Subscribed Shares and Private Placement Warrants.

 

(h)             
Other than where the failure to timely file would not reasonably be expected to have a Company Material Adverse Effect, as of their
respective dates, all reports required to be filed by the Company with the Commission (the “SEC Reports”)
complied in all material respects with the applicable requirements in existence as of such dates of the Securities Act and the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to make the statements therein, as of such dates, in the
light of the circumstances under which they were made, not misleading. Except as disclosed in the SEC Reports, the financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and
the rules and regulations of the Commission with respect thereto as in effect at the time of filing and fairly present in all
material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments.

 

    6

     

    

 

(i)              
As of the date hereof, and immediately prior to the Closing when the Company’s amended and restated memorandum and articles of association
shall be amended and restated to effect the Transaction, the entire authorized share capital stock of the Company consists of 200,000,000
Class A ordinary shares (“Class A Shares”), 20,000,000 Class B ordinary shares, and 1,000,000 preference shares, par
value $0.0001 per share (“Preference Shares”). As of the Closing Date (and immediately after the consummation of the
Transaction), the entire authorized capital stock of the Company will consist of [●] Ordinary Shares and [●] Preference Shares.

 

(j)              
Assuming the accuracy of all of Subscriber’s representations and warranties set forth in Section 4 of this Subscription Agreement,
no registration under the Securities Act is required for the offer and sale of the Subscribed Shares and Private Placement Warrants by
the Company to Subscriber and the Subscribed Shares and Private Placement Warrants are not being offered in a manner involving a public
offering under, or in a distribution in violation of, the Securities Act or any state securities law.

 

(k)             
Neither the Company nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general advertising
(within the meaning of Regulation D) in violation of the Securities Act in connection with any offer or sale of the Subscribed Shares
and Private Placement Warrants.

 

(l)              
No broker or finder is entitled to any brokerage or finder’s fee or commission from the Company solely in connection with the sale
of the Subscribed Shares and Private Placement Warrants to Subscriber.

 

(m)           
The Company has provided Subscriber an opportunity to ask questions regarding the Company and made available to Subscriber all the information
reasonably available to the Company that Subscriber has reasonably requested to make an investment decision with respect to the Subscribed
Shares and the Private Placement Warrants.

 

(n)             
Except for such matters as have not had and would not reasonably be expected to have a Company Material Adverse Effect, the Company is
in compliance with all laws applicable to the conduct of its business. The Company has not received any written, or to its knowledge,
other communication from a governmental entity that alleges that the Company is not in compliance with or is in default or violation of
any applicable law, except where such non-compliance, default or violation would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect.

 

(o)             
As of the date hereof, the issued and outstanding Class A Shares are registered pursuant to Section 12(b) of the Exchange Act and listed
for trading on the NYSE. There is no suit, action, claim, proceeding or investigation pending or, to the knowledge of the Company, threatened
against the Company by NYSE or the Commission with respect to any intention by such entity to deregister the Class A Shares or to prohibit
or terminate the listing of the Class A Shares on NYSE, excluding, for the purposes of clarity, the customary ongoing review by NYSE in
connection with the Transaction.

 

(p)             
There are no shareholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it
is bound relating to the voting of any securities of the Company, other than (1) as set forth in the SEC Reports and (2) as contemplated
by the Business Combination Agreement.

 

    7

     

    

 

(q)             
The Company has not engaged in any “directed selling efforts” (within the meaning of Regulation S) with respect to the Subscribed
Shares or the Private Placement Warrants, and the Company and its affiliates have complied with the offering restrictions requirement
of Regulation S. The Company is a “foreign issuer” as defined in Regulation S.

 

(r)              
The Other Subscription Agreements reflect the same Per Unit Subscription Price and other terms with respect to the purchase of the Other
Subscribed Shares and Other Private Placement Warrants that are no more favorable to the Other Subscribers thereunder than the terms of
this Subscription Agreement, other than terms particular to the regulatory requirements of such Other Subscribers or their affiliates
or related funds that are mutual funds or are otherwise subject to regulations related to the timing of funding and the issuance of the
related Other Subscribed Shares and Other Private Placement Warrants.

 

4.               
Subscriber Representations and Warranties. Subscriber represents and warrants to the Company that as the date hereof:

 

(a)             
Subscriber (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation, and (ii)
has the requisite power and authority to enter into and perform its obligations under this Subscription Agreement.

 

(b)             
This Subscription Agreement has been duly executed and delivered by Subscriber, and assuming the due authorization, execution and delivery
of the same by the Company, this Subscription Agreement shall constitute the valid and legally binding obligation of Subscriber, enforceable
against Subscriber in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium and similar laws affecting creditors generally and by the availability of equitable remedies.

 

(c)             
The execution and delivery of this Subscription Agreement, the purchase of the Subscribed Shares and Private Placement Warrants and the
compliance by Subscriber with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated
herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under,
or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of Subscriber pursuant to
the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber
is a party or by which Subscriber is bound or to which any of the property or assets of Subscriber is subject; (ii) the organizational
documents of Subscriber; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body,
domestic or foreign, having jurisdiction over Subscriber or any of its properties that, in the case of clauses (i) and (iii), would reasonably
be expected to have a Subscriber Material Adverse Effect. For purposes of this Subscription Agreement, a “Subscriber Material
Adverse Effect” means an event, change, development, occurrence, condition or effect with respect to Subscriber that would reasonably
be expected to have a material adverse effect on Subscriber’s ability to timely consummate the transactions contemplated hereby,
including the purchase of the Subscribed Shares and Private Placement Warrants.

 

    8

     

    

 

(d)             
(i) If Subscriber is located in the United States or is a U.S. person, Subscriber (A) is a “qualified institutional buyer”
(as defined in Rule 144A under the Securities Act) or an institutional “accredited investor” (within the meaning of Rule
501(a)(1), (2), (3), (7), (9) or (12) under the Securities Act), in either case satisfying the applicable requirements set forth on Annex
A hereto and an “institutional account” as defined in FINRA Rule 4512(c), and is not an entity formed for the specific purpose
of acquiring the Subscribed Shares or the Private Placement Warrants and is an “institutional account” as defined by FINRA
Rule 4512(c) and a sophisticated institutional investor, experienced in investing in private equity transactions and capable of evaluating
investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or
securities; (B) is a sophisticated investor, experienced in investing in private equity transactions and capable of evaluating investment
risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities,
(C) has exercised independent judgment in evaluating its participation in the purchase of the Subscribed Shares and the Private Placement
Warrants, (D) is acquiring the Subscribed Shares and the Private Placement Warrants only for its own account and not for the account
of others, or if Subscriber is subscribing for the Subscribed Shares and the Private Placement Warrants as a fiduciary or agent for one
or more investor accounts, each owner of such account is a qualified institutional buyer or an institutional accredited investor and
Subscriber has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements,
representations and agreements herein on behalf of each owner of each such account, and (E) is not acquiring the Subscribed Shares or
the Private Placement Warrants with a view to, or for offer or sale in connection with, any distribution thereof in violation of the
Securities Act (and has provided the Company with the requested information on Annex
A), and (F) understands that the offering meets the exemptions from filing under FINRA Rules 5123(b)(1)(A), (C) and (J); and (ii) if
located outside the United States and not a U.S. person, (A) Subscriber is acquiring the Subscribed Shares and the Private Placement
Warrants in an "offshore transaction" meeting the requirements of Rule 903 of Regulation S under the Securities Act, (B) Subscriber
understand that the offering meets the exemptions from filing under FINRA Rule 5123(c), (C) Subscriber is are aware that the sale to
them is being made in reliance on a private placement exemption from, or in a transaction not subject to, registration under the Securities
Act, and the purchaser and the person, if any, for whose account or benefit the purchaser is acquiring the Securities offered pursuant
to this Subscription, was located outside the United States and was not a U.S. person at the time (x) the offer was made to it and (y)
when the buy order for such Subscribed Shares and Private Placement Warrants was originated, and continues to be located outside the
United States and not to be a U.S. person and has not purchased such Subscribed Shares or Private Placement Warrants for the account
or benefit of any person located in the United States or who is a U.S. person, or entered into any arrangement for the transfer of such
Subscribed Shares, Private Placement Warrants or any economic interest therein to any person located in the United States or any U.S.
person, (D) Subscriber is authorized to consummate the purchase of the Subscribed Shares and the Private Placement Warrants offered pursuant
to this Subscription in compliance with all applicable laws and regulations of the jurisdiction where such sales are to be made. In either
case, the Subscribed Shares and the Private Placement Warrants have not been registered under the Securities Act or any other applicable
securities laws of any other jurisdiction, are being offered in transactions not requiring registration under the Securities Act, and
unless so registered, may not be reoffered, resold or otherwise transferred except in compliance with the registration requirements of
the Securities Act or any other applicable securities laws, pursuant to any exemption therefrom or in a transaction not subject thereto.
Subscriber understands that each of the Subscribed Shares and the Private Placement Warrants may not be offered, resold, transferred,
pledged (other than in connection with ordinary course prime brokerage relationships) or otherwise disposed of by Subscriber absent an
effective registration statement under the Securities Act, except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons
pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii)
pursuant to another applicable exemption from the registration requirements of the Securities Act, and, in each of cases (ii) and (iii),
in accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any book-entry
positions or certificates representing the Subscribed Shares and the Private Placement Warrants shall contain the legend set forth in
this Section 4(d). Subscriber understands and agrees that the Subscribed Shares and the Private Placement Warrants will be subject
to transfer restrictions under applicable securities laws and, as a result of these transfer restrictions, Subscriber may not be able
to readily offer, resell, transfer, pledge (other than in connection with ordinary course prime brokerage relationships) or otherwise
dispose of the Subscribed Shares or the Private Placement Warrants and may be required to bear the financial risk of an investment in
the Subscribed Shares and the Private Placement Warrants for an indefinite period of time. Subscriber understands that it has been advised
to consult legal counsel and tax and accounting advisors prior to making any offer, resale, pledge, transfer or disposition of any of
the Subscribed Shares or the Private Placement Warrants.

 

    9

     

    

 

Each book entry for the Subscribed Shares
and the Private Placement Warrants shall contain a notation, and each certificate (if any) evidencing the Shares shall be stamped or otherwise
imprinted with a legend, in substantially the following form (or to substantially the following effect):

 

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED
OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE (NOTWITHSTANDING THE FOREGOING, THE SECURITIES REPRESENTED HEREBY
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES). BY ITS
ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER AGREES FOR THE BENEFIT OF ZURA BIO LTD. (THE “COMPANY”)
THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE
LATER OF (X) ONE YEAR AFTER THE ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR
ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT:

 

(A)            
TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR

 

(B)            
PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT AND IS EFFECTIVE AT THE TIME OF SUCH TRANSFER,
OR

 

(C)            
PURSUANT TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES
ACT, OR

 

(D)            
PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.

 

PRIOR TO THE REGISTRATION OF ANY PERMITTED
TRANSFER IN ACCORDANCE WITH THE ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR
OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT.

 

    10

     

    

 

(e)             
Subscriber understands and agrees that Subscriber is purchasing the Subscribed Shares and the Private Placement Warrants directly
from the Company. Subscriber further acknowledges that there have not been, and Subscriber hereby expressly and irrevocably
acknowledges and agrees that it is not relying on, any representations, warranties, covenants or, agreements or statements made to
Subscriber by or on behalf of the Company, Zura or the Company’s or Zura’s respective affiliates or any of the
respective subsidiaries, control persons, officers, directors, employees, partners, agents or representatives, or any other party to
the Transaction or any other person or entity, expressly or by implication, (including by omission), other than those
representations, warranties, covenants, agreements and statements of the Company expressly set forth in this Subscription Agreement,
and Subscriber is not relying on any other purported representations, warranties, covenants, agreements or statements (including by
omission). Subscriber acknowledges that certain information provided by the Company was based on projections, and such projections
were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant
business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained
in the projections. Subscriber undertook this investment freely and after obtaining independent legal advice.

 

(f)              
In making its decision to purchase the Subscribed Shares and Private Placement Warrants, Subscriber has relied solely upon independent
investigation made by Subscriber and upon the representations, warranties and covenants of the Company expressly set forth herein (and
no other representations and warranties). Subscriber acknowledges and agrees that Subscriber has received and had adequate time to review
such information as Subscriber deems necessary in order to make an investment decision with respect to the Subscribed Shares and the Private
Placement Warrants, including with respect to the Company and the Transaction (including Zura and its subsidiaries (collectively, the
 “Acquired Companies”)). Subscriber acknowledges it has conducted its own investigation of the Company and the Subscribed
Shares and Private Placement Warrants and has been offered the opportunity to ask questions of the Company and received answers thereto,
including on the financial information, as Subscriber deemed necessary in connection with its decision to purchase the Subscribed Shares
and the Private Placement Warrants. Subscriber has made its own assessment and is satisfied concerning the relevant tax and other economic
considerations relevant to its investment in the Subscribed Shares and the Private Placement Warrants. Without limiting the generality
of the foregoing, Subscriber acknowledges that Subscriber has reviewed the SEC Reports. Subscriber represents and agrees that Subscriber
and Subscriber’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and
obtain such information as Subscriber and such undersigned’s professional advisor(s), if any, have deemed necessary to make an investment
decision with respect to the Subscribed Shares and the Private Placement Warrants.

 

(g)             
Subscriber became aware of this offering of the Subscribed Shares and the Private Placement Warrants solely by means of direct
contact between Subscriber and the Company or by means of contact from Zura or its subsidiaries and/or their respective advisors
(including, without limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons,
representatives, affiliates, directors, officers, managers, members, and/or employees, and/or the representatives of such persons
(such parties referred to collectively as “Representatives”). The Subscribed Shares and the Private Placement
Warrants were offered to Subscriber solely by direct contact between Subscriber and the Company, Zura or its subsidiaries and/or
their respective Representatives. Subscriber did not become aware of this offering of the Subscribed Shares and the Private
Placement Warrants, nor were the Subscribed Shares and Private Placement Warrants offered to Subscriber, by any other means, and
none of the Company, Zura or its subsidiaries or their respective Representatives acted as investment advisor, broker or dealer to
Subscriber. Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty
made by any person or entity (including, without limitation, the Company, Zura and/or their respective Representatives), other than
the representations and warranties expressly set forth in this Subscription Agreement, in making its investment or decision to
invest in the Company. Subscriber acknowledges that the Company represents and warrants that the Subscribed Shares and Private
Placement Warrants (i) were not offered by any form of general solicitation or general advertising, including methods described in
Section 502(c) of Regulation D under the Securities Act, and (ii) are not being offered in a manner involving a public offering
under, or in a distribution in violation of, the Securities Act, or any state securities laws.

 

    11

     

    

 

(h)             
Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Subscribed Shares
and the Private Placement Warrants. Subscriber has such knowledge and experience in financial and business matters as to be capable of
evaluating the merits and risks of an investment in the Subscribed Shares and the Private Placement Warrants, and Subscriber has had an
opportunity to seek, and has sought, such accounting, legal, business and tax advice as Subscriber has considered necessary to make an
informed investment decision, and has the ability to bear the economic risks of its prospective investment and can afford the complete
loss of such investment. Subscriber acknowledges that it (i) is a sophisticated investor, experienced in investing in business and financial
transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment
strategies involving a security or securities, and (ii) has exercised independent judgment in evaluating its purchase of the Subscribed
Shares and the Private Placement Warrants. Subscriber acknowledges that its purchase of Subscribed Shares and the Private Placement Warrants
(i) is fully consistent with Subscriber’s financial needs, objectives and condition, (ii) complies and is fully consistent with
all of Subscriber’s applicable investment policies, guidelines and other restrictions, (iii) has been duly authorized and approved
by all necessary action (corporate or otherwise), and (iv) does not and will not violate or constitute a default under Subscriber’s
charter, by-laws or other constituent documents or under any law, rule, regulation, agreement or other obligation by which we are
bound and are a fit, proper and suitable investment, notwithstanding the substantial risks inherent in investing in or holding the Subscribed
Shares or the Private Placement Warrants. Subscriber understands that the purchase and sale of the Subscribed Shares and the Private Placement
Warrants, to the extent applicable, hereunder meets (i) the institutional accounts exemptions from filing under FINRA Rule 5123(b)(1)(A),
(ii) the institutional customer exemption from filing under FINRA Rule 2111(b), (iii) the qualified institutional buyers exemption from
filing under FINRA Rule 5123(b)(1)(C) and (iv) the accredited investors exemption from filing under FINRA Rule 5123(b)(1)(J).

 

(i)              
Alone, or together with any professional advisor(s), Subscriber represents and acknowledges that Subscriber has adequately analyzed and
fully considered the risks of an investment in the Subscribed Shares and the Private Placement Warrants and determined that the Subscribed
Shares and the Private Placement Warrants are a suitable investment for Subscriber and that Subscriber is able at this time and in the
foreseeable future to bear the economic risk of a total loss of Subscriber’s investment in the Company. Subscriber acknowledges
specifically that a possibility of total loss exists.

 

(j)              
Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Subscribed
Shares or the Private Placement Warrants or made any findings or determination as to the fairness of this investment.

 

    12

     

    

 

(k)             
Subscriber is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the
U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by
the President of the United States and administered by OFAC, or any other list of prohibited or restricted parties promulgated by
OFAC, the Department of Commerce, or the Department of State (“Consolidated Sanctions Lists”), or a person or
entity prohibited or restricted by any OFAC sanctions program, or a person or entity whose property and interests in property
subject to U.S. jurisdiction are otherwise blocked under any U.S. laws, Executive Orders or regulations, (ii) a person or entity
listed on the Sectoral Sanctions Identifications (“SSI”) List maintained by OFAC or otherwise determined by OFAC
to be subject to one or more of the Directives issued under Executive Order 13662 of March 20, 2014, or on any other of the
Consolidated Sanctions Lists, (iii) an entity owned, directly or indirectly, individually or in the aggregate, 50 percent or
more by, acting on behalf of, or controlled by, one or more persons described in subsections (i) or (ii), (iv) organized,
incorporated, established, located, resident or born in, or a citizen, national or the government, including any political
subdivision, agency or instrumentality thereof, of, Cuba, Iran, North Korea, Myanmar, Venezuela, Syria, the Crimea region of
Ukraine, the so-called People’s Republics of Luhansk
and Donetsk of Ukraine or any other country or territory embargoed or subject to substantial trade restrictions by the United
States, (v) a person or entity named on the U.S. Department of Commerce, Bureau of Industry and Security (“BIS”)
Denied Persons List, Entity List, or Unverified List (“BIS Lists”), (vi) a Designated National as defined in the
Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (vii) a non-U.S. shell bank or providing banking services indirectly
to a non-U.S. shell bank (collectively, (i) through (vii), a “Restricted Person”). Subscriber agrees to provide
law enforcement agencies, if requested thereby, such records as required by applicable law, provided that Subscriber is permitted to
do so under applicable law. Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act
(31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001 and its implementing regulations (collectively, the
 “BSA/PATRIOT Act”), that Subscriber maintains policies and procedures reasonably designed to comply with
applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it maintains policies and
procedures reasonably designed for the screening of its investors against the OFAC and BIS sanctions programs, including for
Restricted Persons, and otherwise to ensure compliance with all applicable sanctions and embargo laws, statutes, and regulations.
Subscriber further represents and warrants that, to the extent required, it maintains policies and procedures reasonably designed to
ensure that the funds held by Subscriber and used to purchase the Subscribed Shares and Private Placement Warrants were legally and
were not obtained, directly or indirectly, from a Restricted Person. Subscriber is not a “foreign person,”
 “foreign government,” or a “foreign entity,” in each case, as defined in Section 721 of the Defense
Production Act of 1950, as amended, including, without limitation, all implementing regulations thereof (the
 “DPA”). Subscriber is not controlled, in whole or in part, by a “foreign person,” as defined in the
DPA.

 

(l)              
Subscriber does not have, as of the date hereof, and during the 30-day period immediately prior to the date hereof Subscriber has not
entered into, any “put equivalent position” as such term is defined in Rule 16a-1 under the Exchange Act or short sale positions
with respect to the securities of the Company. Notwithstanding the foregoing, in the case of a Subscriber that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of Subscriber’s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio managers managing other portions of Subscriber’s assets, the representation
set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Subscribed Shares and the Private Placement Warrants covered by this Subscription Agreement.

 

(m)           
If Subscriber is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account or other
arrangement that is subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), or an
employee benefit plan that is a governmental plan (as defined in Section 3(32) of ERISA), a church plan (as defined in Section 3(33)
of ERISA), a non-U.S. plan (as described in Section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing but
may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such
provisions of ERISA or the Code, or an entity whose underlying assets are considered to include “plan assets” of any
such plan, account or arrangement (each, a “Plan”) subject to the fiduciary or prohibited transaction provisions
of ERISA or Section 4975 of the Code or other laws or regulations that are similar to such provisions, then Subscriber represents
and warrants that neither the Company, nor any of its respective affiliates (the “Transaction Parties”) has acted
as the Plan’s fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Subscribed
Shares and Private Placement Warrants, and none of the Transaction Parties shall at any time be relied upon as the Plan’s
fiduciary with respect to any decision to acquire, continue to hold or transfer the Subscribed Shares and the Private Placement
Warrants.

 

    13

     

    

 

(n)             
At the Closing, Subscriber will have sufficient funds to pay the Subscription Amount pursuant to Section 2(b) of this Subscription
Agreement.

 

(o)             
Subscriber agrees that, notwithstanding Section 9(i) of this Subscription Agreement, the Company and Zura may rely upon the representations
and warranties made by Subscriber to the Company in this Subscription Agreement.

 

(p)             
No broker, finder or other financial consultant has acted on behalf of Subscriber in connection with this Subscription Agreement or the
transactions contemplated hereby in such a way as to create any liability on the Company.

 

(q)             
Except for the representations and warranties contained in this Section 4, Subscriber makes no express or implied representation
or warranty, and Subscriber hereby disclaims any such representation or warranty with respect to the execution and delivery of this Subscription
Agreement and the consummation of the transactions contemplated herein.

 

		5.	Registration of Subscribed Shares and Ordinary Shares Issuable Upon Exercise of Private Placement Warrants.

 

(a)             
The Company agrees that, within 45 calendar days after the consummation of the Transaction (the “Filing
Deadline”), the Company will file with the Commission (at the Company’s sole cost and expense) a registration
statement (the “Registration Statement”) registering the resale of the Subscribed Shares and the Ordinary Shares
issuable upon exercise of the Private Placement Warrants, and the Company shall use its commercially reasonable efforts to have the
Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the 60th calendar
day (or 120th calendar day if the Commission notifies the Company that it will “review” the Registration
Statement) following the Filing Deadline (such date, the “Effectiveness Date”); provided, however, that the
Company’s obligations to include the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement
Warrants in the Registration Statement are contingent upon the undersigned furnishing in writing to the Company such information
regarding the undersigned, the securities of the Company held by the undersigned and the intended method of disposition of the
Subscribed Shares and the Ordinary Shares issuable upon exercise of the Private Placement Warrants as shall be reasonably requested
by the Company to effect the registration of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private
Placement Warrants, and shall execute such documents in connection with such registration as the Company may reasonably request that
are customary of a selling shareholder in similar situations. Notwithstanding the foregoing, if the Effectiveness Date falls on a
day which is not a Business Day or other day that the Commission is closed for business, the Effectiveness Date shall be extended to
the next Business Day on which the Commission is open for business. Further notwithstanding the foregoing, if the Commission
prevents the Company from including any or all of the shares proposed to be registered under the Registration Statement due to
limitations on the use of Rule 415 of the Securities Act for the resale of the respective Aggregate Subscribed Shares and Ordinary
Shares issuable upon exercise of the Aggregate Private Placement Warrants, such Registration Statement shall register for resale
such number of Aggregate Subscribed Shares and Ordinary Shares issuable upon exercise of the Aggregate Private Placement Warrants
that is equal to the maximum number of Aggregate Subscribed Shares and Ordinary Shares issuable upon exercise of the Aggregate
Private Placement Warrants as is permitted by the Commission. In such event, the number of Subscribed Shares, Other Subscribed
Shares or Ordinary Shares issuable upon exercise of the Private Placement Warrants and Other Private Placement Warrants to be
registered for each selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling
shareholders. For purposes of clarification, any failure by the Company to file the Registration Statement by the Filing Deadline or
to effect such Registration Statement by the Effectiveness Date shall not otherwise relieve the Company of its obligations to file
or effect the Registration Statement set forth in this Section 5.

 

    14

     

    

 

(b)             
In the case of the registration, qualification, exemption or compliance effected by the Company pursuant to this Subscription Agreement,
the Company shall, upon reasonable request, respond to Subscriber as to the status of such registration, qualification, exemption and
compliance. At its expense the Company shall:

 

(i)              
except for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement,
use its commercially reasonable efforts to maintain the continuous effectiveness of the Registration Statement, and cause the Registration
Statement to be supplemented and amended to the extent necessary to ensure that such Registration Statement is available or, if not available,
that another registration statement is available for the resale of the Subscribed Shares and the Ordinary Shares issuable upon exercise
of the Private Placement Warrants, until the earliest of (i) the date on which the Subscribed Shares and the Ordinary Shares issuable
upon exercise of the Private Placement Warrants may be resold without volume or manner of sale limitations pursuant to Rule 144 promulgated
under the Securities Act, (ii) the date on which such Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement
Warrants have actually been sold pursuant to Rule 144 or pursuant to the Registration Statement, and (iii) the date which is two years
after the Closing.

 

(ii)             
advise Subscriber, as expeditiously as possible:

 

(1)             
when a Registration Statement or any amendment thereto has been filed with the Commission;

 

(2)             
after it shall receive notice or obtain knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for such purpose;

 

(3)             
of the receipt by the Company of any notification with respect to the suspension of the qualification of the Subscribed Shares or Ordinary
Shares issuable upon exercise of the Private Placement Warrants included therein for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose; and

 

(4)             
subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in
any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to
state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the
light of the circumstances under which they were made) not misleading.

 

    15

     

    

 

Notwithstanding anything
to the contrary set forth herein, the Company shall not, when so advising Subscriber of such events, provide Subscriber with any material,
nonpublic information regarding the Company other than to the extent that providing notice to the Subscriber of the occurrence of the
events listed in (1) through (4) above may constitute material, nonpublic information regarding the Company;

 

(iii)            
use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as soon as reasonably practicable;

 

(iv)            
upon the occurrence of any event contemplated in Section 5(b)(ii)(4) above, except for such times as the Company is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Company shall use its commercially
reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement or a supplement
to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Subscribed Shares
and Ordinary Shares issuable upon exercise of the Private Placement Warrants included therein, such prospectus will not include any untrue
statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading;

 

(v)             
cause the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants to be listed on each securities
exchange or market, if any, on which the Ordinary Shares issued by the Company have been listed;

 

(vi)            
use its commercially reasonable efforts to allow Subscriber to review disclosure regarding Subscriber in the Registration Statement;

 

(vii)          
for as long as Subscriber holds Subscribed Shares or Private Placement Warrants, use commercially reasonable efforts to file all reports
for so long as the condition in Rule 144(c)(1) (or Rule 144(i)(2), if applicable) is required to be satisfied, and provide all customary
and reasonable cooperation, necessary to enable the undersigned to resell the Subscribed Shares or the Ordinary Shares issuable upon exercise
of the Private Placement Warrants, as applicable, pursuant to Rule 144 of the Securities Act (in each case, when Rule 144 of the Securities
Act becomes available to Subscriber); and

 

(viii)         
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by Subscriber, consistent
with the terms of this Subscription Agreement, in connection with the registration of the Subscribed Shares and Ordinary Shares issuable
upon exercise of the Private Placement Warrants.

 

    16

     

    

 

(c)             
Notwithstanding anything to the contrary in this Subscription Agreement, the Company shall be entitled to delay or postpone the effectiveness
of the Registration Statement, and from time to time to require any Subscriber not to sell under the Registration Statement or to suspend
the effectiveness thereof, (x) if (i) it determines that in order for the Registration Statement not to contain a material misstatement
or omission, an amendment or supplement thereto would be needed or (ii) the negotiation or consummation of a transaction by the Company
or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event, the Company reasonably believes, upon
the advice of legal counsel, would require additional disclosure by the Company in the Registration Statement of material information
that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
would be expected, in the reasonable determination of the Company, upon the advice of legal counsel, to cause the Registration Statement
to fail to comply with applicable disclosure requirements and (y) as may be necessary in connection with the preparation and filing of
a post-effective amendment to the Registration Statement following the filing of the Company’s (including the combined company
after giving effect to the Transaction) Annual Report on Form 20-F, or 10-K, as appropriate, for its first completed fiscal year following
the Closing (each such circumstance, a “Suspension Event”); provided, however, that the Company may not delay or suspend
the Registration Statement on more than three occasions or for more than ninety consecutive calendar days, or more than a total of 120
calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Company of the happening of any
Suspension Event (which notice shall not contain material non-public information) during the period that the Registration Statement is
effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a
material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made (in the case of the prospectus) not misleading, Subscriber agrees that (i) it will immediately
discontinue offers and sales of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants under
the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until Subscriber receives copies
of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the misstatement(s) or omission(s)
referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Company
that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any information included in such written
notice delivered by the Company unless otherwise required by law or subpoena. If so directed by the Company, Subscriber will deliver
to the Company or, in Subscriber’s sole discretion destroy, all copies of the prospectus covering the Subscribed Shares and Ordinary
Shares issuable upon exercise of the Private Placement Warrants in Subscriber’s possession; provided, however, that this obligation
to deliver or destroy all copies of the prospectus covering the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private
Placement Warrants shall not apply (i) to the extent Subscriber is required to retain a copy of such prospectus (a) in order to
comply with applicable legal, regulatory, self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing
document retention policy or (ii) to copies stored electronically on archival servers as a result of automatic data back-up.

 

(d)             
The Company shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Subscriber (to
the extent a seller under the Registration Statement), and its officers, directors and agents, and each person who controls Subscriber
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i)
any untrue or alleged untrue statement of a material fact contained in the Registration Statement, any prospectus included in the Registration
Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange Act or any state securities
law or any rule or regulation thereunder, in connection with the performance of its obligations under this Section 5,
except, in each case, to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged
omissions are based upon information regarding Subscriber furnished in writing to the Company by Subscriber expressly for use therein
or such Subscriber has omitted a material fact from such information or otherwise violated the Securities Act, Exchange Act or any state
securities law or any rule or regulation thereunder; provided, however, that the indemnification contained in this Section 5 shall
not apply to amounts paid in settlement of any Losses if such settlement is effected by Subscriber without the consent of the Company
(which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Company be liable for any Losses to the extent
they arise out of or are based upon a violation which occurs (A) in reliance upon and in conformity with written information furnished
by a Subscriber, (B) in connection with any failure of Subscriber to deliver or cause to be delivered a prospectus made available to
Subscriber by the Company in a timely manner, (C) as a result of offers or sales effected by or on behalf of Subscriber by means of a
freewriting prospectus (as defined in Rule 405) that was not authorized by the Company, or (D) in connection with any offers or sales
effected by or on behalf of a Subscriber in violation of Section 5(b) of this Subscription Agreement. The Company shall notify
such Subscriber promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions
contemplated by this Section 5 of which the Company is aware. The indemnity set forth in this Section 5(d) shall remain
in full force and effect regardless of any investigation made by or on behalf of an indemnified party and shall survive the transfer
of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants by Subscriber.

 

    17

     

    

 

(e)             
If the total number of Ordinary Shares that Subscriber and any other person(s) intend to include in an underwritten offering exceeds the
number of Ordinary Shares that can be sold in an underwritten offering without being likely to have an adverse effect on the price, timing
or distribution of Ordinary Shares offered or the market for the Ordinary Shares as determined by the managing underwriter of such offering,
then the Ordinary Shares to be included in such offering shall include the number of Ordinary Shares that the managing underwriter of
the offering advises the Company can be sold without having such adverse effect, with such number to be allocated (i) first, to the Company
or other party or parties requesting or initiating such registration or to any other holder of securities of the Company having rights
of registration pursuant to an existing registration rights agreement and (ii) second, Subscribers, allocated among Subscribers on the
basis of the number of Ordinary Shares proposed to be sold by each applicable member of Subscribers in such underwritten offering (based,
for each such participant, described in this clause (ii), on the percentage derived by dividing (x) the number of Ordinary Shares proposed
to be sold by such participant in such underwritten offering by (y) the aggregate number of Ordinary Shares proposed to be sold by all
such participants) or in such manner as they may agree, and (iii) third, to other holders of Ordinary Shares with registration rights
entitling them to participate in such underwritten offering.

 

(f)              
Subscriber, severally and not jointly with the Other Subscribers, shall indemnify and hold harmless the Company, its directors,
officers, agents, trustees, partners, members, managers, shareholders, affiliates, investment advisors and employees, and each
person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the
fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or based upon any untrue or
alleged untrue statement of a material fact contained in the Registration Statement, any prospectus included in the Registration
Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which
they were made) not misleading to the extent, but only to the extent, that such untrue statements or omissions are based upon
information regarding Subscriber furnished in writing to the Company by Subscriber expressly for use therein; provided, however,
that the indemnification contained in this Section 5(f) shall
not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of Subscriber (which
consent shall not be unreasonably withheld, conditioned or delayed) nor shall Subscriber be liable for any Losses to the extent they
arise out of or are based upon a violation which occurs in reliance upon and in conformity with written information furnished by the
Company. In no event shall the liability of any Subscriber be greater in amount than the dollar amount of the net proceeds received
by Subscriber upon the sale of the Subscribed Shares or Ordinary Shares issuable upon exercise of the Private Placement Warrants
giving rise to such indemnification obligation. Subscriber shall notify the Company promptly of the institution, threat or assertion
of any proceeding arising from or in connection with the transactions contemplated by this Section 5(f) of which such
Subscriber is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an
indemnified party and shall survive the transfer of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private
Placement Warrants by Subscriber.

 

    18

     

    

 

(g)             
Any person or entity entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s
right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (ii) unless in such indemnified
party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such
claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party.
If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party
without its consent (but such consent shall not be unreasonably withheld, conditioned or delayed). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all
parties indemnified by such indemnifying party with respect to such claims, unless in the reasonable judgment of any indemnified party
a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement), which settlement shall not include a statement or admission of fault and culpability on the part of such indemnified
party, and which settlement shall include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation.

 

(h)             
If the indemnification provided under this Section 5 from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any Losses referred to herein, then the indemnifying party, in lieu of indemnifying the
indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such
proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other
relevant equitable considerations; provided, however, that the liability of Subscriber shall be limited to the net proceeds received
by Subscriber from the sale of Subscribed Shares or Ordinary Shares issuable upon exercise of the Private Placement Warrants giving
rise to such indemnification obligation. The relative fault of the indemnifying party and indemnified party shall be determined by
reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material
fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates
to information supplied by (or not supplied by, in the case of an omission) such indemnifying party or indemnified party, and the
indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to
correct or prevent such action. The amount paid or payable by a party as a result of the Losses shall be deemed to include, subject
to the limitations set forth in this Section 5,
any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution pursuant to this Section 5(h) from any person or entity who was not guilty of such fraudulent
misrepresentation.

 

    19

     

    

 

(i)              
Subscriber may deliver written notice (an “Opt-Out Notice”) to the Company requesting that Subscriber not receive notices
from the Company otherwise required by this Section 5; provided, however, that Subscriber may later revoke any such Opt-Out Notice
in writing. Following receipt of an Opt-Out Notice from Subscriber (unless subsequently revoked), (i) the Company shall not deliver any
such notices to Subscriber and Subscriber shall no longer be entitled to the rights associated with any such notice and (ii) each time
prior to Subscriber’s intended use of an effective Registration Statement, Subscriber will notify the Company in writing at least
two business days in advance of such intended use, and if a notice of a Suspension Event was previously delivered (or would have been
delivered but for the provisions of this Section 5(i)) and the related suspension period remains in effect, the Company will so
notify Subscriber, within one business day of Subscriber’s notification to the Company, by delivering to Subscriber a copy of such
previous notice of Suspension Event, and thereafter will provide Subscriber with the related notice of the conclusion of such Suspension
Event immediately upon its availability (which notices shall not contain any material, nonpublic information or subject Subscriber to
any duty of confidentiality).

 

(j)              
Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation, warranty or other information
made or provided by any person, firm or corporation, other than the statements, representations and warranties expressly contained in
Section 3 of this Subscription Agreement, in making its investment or decision to invest.

 

(k)             
For purposes of this Section 5, (i) “Subscriber” shall include any person to whom the rights under this Section
5 shall have been duly assigned, (ii) “Subscribed Shares” shall mean, as of any date of determination, the Subscribed
Shares acquired by Subscriber pursuant to this Subscription Agreement and any other equity security issued or issuable with respect to
such Subscribed Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event
and (ii) “Private Placement Warrants” shall mean, as of any date of determination, the Private Placement Warrants acquired
by Subscriber pursuant to this Subscription Agreement.

 

6.                Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the
parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to
occur of (a) such date and time as the Business Combination Agreement is terminated in accordance with its terms, (b) upon the
mutual written agreement of the Company and Subscriber to terminate this Subscription Agreement, or (c) January 16, 2023 (the
 “Outside Date”); provided, that nothing herein will relieve any party from liability for any willful breach
hereof (including, for the avoidance of doubt, a Subscriber’s willful breach of Section 2(c) of this Subscription
Agreement with respect to its representations, warranties and covenants as of the date of the Closing) prior to the time of
termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising
from such breach. The Company shall notify Subscriber of the termination of the Business Combination Agreement promptly after the
termination thereof. For the avoidance of doubt, if any termination hereof occurs after the delivery by Subscriber of the
Subscription Amount for the Subscribed Shares and the Private Placement Warrants, the Company shall promptly (but not later than
five business days thereafter) return the Subscription Amount to Subscriber by wire transfer of immediately available funds to the
account specified by Subscriber without any deduction for or on account of any tax, withholding, charges, or set-off.

 

    20

     

    

 

7.               
No Short Sales. Subscriber hereby agrees that, from the date of this Subscription Agreement until the Closing Date (or earlier
termination of this Subscription Agreement), neither Subscriber nor any Person acting on behalf of Subscriber or pursuant to any understanding
with the Subscriber will engage in any Short Sales (as defined below) with respect to securities of the Company, as applicable. For purposes
of this Section 7, “Short Sales” shall mean all “short sales” as defined in Rule 200 promulgated under
Regulation SHO under the Exchange Act, and all short positions effected through any direct or indirect stock pledges (other than pledges
in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar
arrangements (including on a total return basis), or sales or other short transactions through non-U.S. broker dealers or foreign regulated
brokers. Notwithstanding the foregoing, (i) nothing in this Section 7 shall prohibit other entities under common management with Subscriber
that have no knowledge of this Subscription Agreement or of Subscriber’s Subscription (including Subscriber’s controlled affiliates
and/or affiliates) from entering into any Short Sales and (ii) in the case of an Investor that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Investor’s assets and the portfolio managers have no knowledge of the
investment decisions made by the portfolio managers or desks managing other portions of such Investor’s assets, the limitations
set forth in the first sentence of this Section 7 shall only apply with respect to the portion of assets managed by the portfolio managers
or desks that made the investment decision to purchase the Subscribed Shares and Private Placement Warrants covered by this Subscription
Agreement.

 

8.               
Trust Account Waiver. Subscriber hereby acknowledges that the Company has established a trust account (the “Trust Account”)
containing the proceeds of its initial public offering (the “IPO”) and from certain private placements occurring simultaneously
with the IPO (including interest accrued from time to time thereon) for the benefit of the public shareholders of the Company and certain
other parties (including the underwriters of the IPO). For and in consideration of the Company entering into this Subscription Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Subscriber hereby (i) agrees
that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held
in the Trust Account, and shall not make any claim against the Trust Account, in each case, to the extent such claim arises as a result
of, in connection with or relating in any way to this Subscription Agreement or any other matter, and regardless of whether such claim
arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively referred to hereafter
as the “Released Claims”), (ii) irrevocably waives any Released Claims that it may have against the Trust Account now
or in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company, and (iii) will not seek
recourse against the Trust Account for any reason whatsoever; provided however, that nothing in this Section 8 shall be deemed to limit
any Subscriber’s right to distributions or redemptions from the Trust Account in accordance with the Company’s amended and
restated memorandum and articles of association in respect of any redemptions by Subscriber of its Class A Shares currently outstanding
on the date hereof and acquired by any means other than pursuant to this Subscription Agreement. Subscriber agrees not to seek recourse
or make or bring any action, suit, claim or other proceeding against the Trust Account as a result of, or arising out of, this Subscription
Agreement, the transactions contemplated hereby, the Subscribed Shares or the Private Placement Warrants regardless of whether such claim
arises based on contract, tort, equity or any other theory of legal liability. Subscriber acknowledges and agrees that it shall not have
any redemption rights with respect to the Subscribed Shares or the Private Placement Warrants pursuant to the Company’s organizational
documents in connection with the Transaction or any other business combination, any subsequent liquidation of the Trust Account, the Company
or otherwise. In the event Subscriber has any claim against the Company as a result of, or arising out of, this Subscription Agreement,
the transactions contemplated hereby, the Subscribed Shares or the Private Placement Warrants, it shall pursue such claim solely against
the Company and its assets outside the Trust Account and not against the Trust Account or any monies or other assets in the Trust Account.

 

    21

     

    

 

9.               
Miscellaneous.

 

(a)             
All notices, requests, demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim, or
other communication hereunder shall be deemed duly given (i) when delivered personally to the recipient, (ii) when sent by electronic
mail, on the date of transmission to such recipient; (iii) one Business Day after being sent to the recipient by reputable overnight courier
service (charges prepaid), or (iv) four Business Days after being mailed to the recipient by certified or registered mail, return
receipt requested and postage prepaid, and, in each case, addressed to the intended recipient at its address specified on the signature
page hereof or to such electronic mail address or address as subsequently modified by written notice given in accordance with this Section 9(a).

 

(b)             
Subscriber acknowledges that the Company will rely on the acknowledgments, understandings, agreements, representations and warranties
made by Subscriber contained in this Subscription Agreement. Prior to the Closing, Subscriber agrees to promptly notify the Company if
it becomes aware that any of the acknowledgments, understandings, agreements, representations and warranties of Subscriber set forth herein
are no longer accurate in all material respects. The Company acknowledges that Subscriber and others will rely on the acknowledgments,
understandings, agreements, representations and warranties contained in this Subscription Agreement.

 

(c)             
Each of the Company and Subscriber is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested
party as requested or required by law, rule or regulation in any administrative or legal proceeding or official inquiry with respect to
the matters covered hereby; provided that, with respect to production by the Company, such party will provide Subscriber with at least
three Business Days’ prior written notice of such production to the extent legally permissible and subject to Section 9(s).

 

(d)             
Regardless of whether the Closing occurs, Subscriber shall pay all of its own expenses in connection with this Subscription Agreement
and the transactions contemplated herein.

 

(e)             
Neither this Subscription Agreement nor any rights that may accrue to Subscriber hereunder (other than the Subscribed Shares and the Private
Placement Warrants acquired hereunder, if any) may be transferred or assigned. Neither this Subscription Agreement nor any rights that
may accrue to the Company hereunder may be transferred or assigned (provided, that, for the avoidance of doubt, the Company may transfer
the Subscription Agreement and its rights hereunder solely in connection with the consummation of the Transaction and exclusively to another
entity under the control of, or under common control with, the Company). Notwithstanding the foregoing, Subscriber may assign its rights
and obligations under this Subscription Agreement to one or more qualified funds (including other investment funds or accounts managed
or advised by the investment manager who acts on behalf of Subscriber) or, with the Company’s prior written consent, to another
person, provided that no such assignment shall relieve the original Subscriber of its obligations hereunder if any such assignee fails
to perform such obligations, unless the Company has given its prior written consent to such relief, and such assignee agrees in writing
to be bound by the terms hereof.

 

(f)              
[Reserved.]

 

(g)             
All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

    22

     

    

 

(h)             
The Company may request from Subscriber such additional information as the Company may reasonably determine necessary to evaluate the
eligibility of Subscriber to acquire the Subscribed Shares and the Private Placement Warrants, to register the resale of the Subscribed
Shares and the Ordinary Shares issuable upon exercise of the Private Placement Warrants or otherwise consummate or evidence the transaction
contemplated by this Subscription Agreement, and Subscriber shall provide such information as may be reasonably requested, to the extent
readily available and to the extent consistent with its internal policies and procedures provided that Company agrees to keep any such
information provided by Subscriber confidential other than as necessary to include in any registration statement the Company is required
to file hereunder or in connection herewith. Subscriber acknowledges and agrees that if it does not provide the Company with such requested
information, the Company may not be able to register the Subscribed Shares and the Ordinary Shares issuable upon exercise of the Private
Placement Warrants for resale pursuant to Section 5 hereof. Subscriber hereby agrees that the Subscription Agreement, as well
as the nature of Subscriber’s obligations hereunder, may be disclosed in any public announcement or disclosure required by the Commission
and in any registration statement, proxy statement, consent solicitation statement or any other Commission filing to be filed by the Company
in connection with the issuance of the Subscribed Shares and the Private Placement Warrants contemplated by this Subscription Agreement
and/or the Transaction, in each case without Subscriber’s prior written consent.

 

(i)              
This Subscription Agreement may not be amended, modified, waived or terminated except by an instrument in writing, signed by each of the
parties hereto; provided, that this Subscription Agreement may be amended, modified, waived or terminated with the written consent of
the Company and the holders then committed to purchase a majority of the Aggregate Subscribed Shares to be purchased at the Closing, including
each holder (which includes Subscriber, its affiliates and accounts and funds controlled or managed by Subscriber or its affiliates) then
committed to purchase at least $[__________] of the Aggregate Subscribed Shares (or, if after the Closing, the Company and the holders
then holding a majority of the then outstanding Aggregate Subscribed Shares. Upon the effectuation of such waiver, modification, amendment
or termination in conformance with this Section 9(i), such amendment, modification, waiver or termination shall be binding on Subscriber
and effective as to all of this Subscription Agreement. The Company shall promptly give written notice thereof to Subscriber if Subscriber
has not previously consented to such amendment, modification, waiver or termination in writing; provided that the failure to give such
notice shall not affect the validity of such amendment, modification, waiver or termination. Notwithstanding anything to the contrary
herein, (i) any amendment, modification or waiver that has a disproportionate effect on Subscriber (considered apart from any disproportionate
effect owing to the aggregate amount of the Subscribed Shares held by such Subscriber), relative to any of the Other Subscribers shall
require the consent of Subscriber and (ii) any amendment to Section 5 or Section 6 of this Subscription Agreement shall
require the consent of Subscriber.

 

(j)              
This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations
and warranties, both written and oral, among the parties hereto, with respect to the subject matter hereof, except that any confidentiality
agreement with respect to the undersigned or its affiliates shall remain in full force and effect following the amendment, modification,
waiver or termination of this Subscription Agreement.

 

    23

     

    

 

(k)             
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties
hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements,
representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such
heirs, executors, administrators, successors, legal representatives and permitted assigns. In addition to, and notwithstanding
anything contained herein to the contrary, (i) the Company acknowledges and agrees that Zura is a third-party beneficiary of the
acknowledgments, understandings, agreements, covenants, representations and warranties made by the Company contained in this
Subscription Agreement, and (ii) the Subscriber acknowledges and agrees that Zura is a third-party beneficiary of the
acknowledgments, understandings, agreements, covenants, representations and warranties made by the Subscriber contained in this
Subscription Agreement. Each of the parties hereto shall be entitled to seek and obtain equitable relief, without proof of actual
damages, including an injunction or injunctions or order for specific performance to prevent breaches of this Subscription Agreement
and to enforce specifically the terms and provisions of this Subscription Agreement to cause Subscriber to fund the Subscription
Amount and cause the Closing to occur if the conditions in Section 2 this
Subscription Agreement have been satisfied or, to the extent permitted by applicable law, waived by the applicable party entitled to
waive any such condition. Each party hereto further agrees that neither the parties hereto nor Zura shall be required to obtain,
furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section
9(k), and each party hereto irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such
bond or similar instrument.

 

(l)              
If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of
the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full
force and effect. Prior to or at the Closing, Subscriber shall deliver to the Company a duly completed and executed Internal Revenue Service
Form W-9 or appropriate Form W-8.

 

(m)           
This Subscription Agreement may be executed and delivered in one or more counterparts (including by facsimile or electronic mail or in
..pdf or any other form of electronic delivery (including any electronic signature complying with U.S. federal ESIGN Act of 2000)) and
by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

(n)             
The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto and
Zura shall be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of this Subscription Agreement
and to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which
such party is entitled to seek at law, in equity, in contract, in tort or otherwise. The parties hereto further agree not to assert that
a remedy of specific enforcement pursuant to this Section 9(n) is unenforceable, invalid, contrary to applicable law or inequitable
for any reason and to waive any defenses in any action for specific performance, including the defense that a remedy at law would be adequate.
In addition, the prevailing party in any action to enforce the provisions of this agreement shall be entitled to fees and expenses incurred
in connection therewith. The parties acknowledge and agree that this Section 9(n) is an integral part of the transactions contemplated
hereby and without that right, the parties hereto would not have entered into this Subscription Agreement.

 

(o)             
This Subscription Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard
to the principles of conflicts of laws that would otherwise require the application of the law of any other jurisdiction.

 

    24

     

    

 

(p)             
EACH PARTY HEREBY WAIVES ITS RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OR RELATED
TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT
BY ANY PARTY AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS OR
OTHERWISE. THE PARTIES AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE
FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION,
COUNTERCLAIM OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS SUBSCRIPTION AGREEMENT
OR ANY PROVISION HEREOF. THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS SUBSCRIPTION
AGREEMENT.

 

(q)             
The parties agree that all disputes, legal actions, suits and proceedings arising out of or relating to this Subscription Agreement must
be brought exclusively in the state courts of New York or in the federal courts located in the state and county of New York (collectively
the “Designated Courts”). Each party hereby consents and submits to the exclusive jurisdiction of the Designated Courts.
No legal action, suit or proceeding with respect to this Subscription Agreement may be brought in any other forum. Notwithstanding the
foregoing, a final judgement in any such action may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law. Each party hereby irrevocably waives all claims of immunity from jurisdiction and any objection which such party may
now or hereafter have to the laying of venue of any suit, action or proceeding in any Designated Court, including any right to object
on the basis that any dispute, action, suit or proceeding brought in the Designated Courts has been brought in an improper or inconvenient
forum or venue. Each of the parties also agrees that delivery of any process, summons, notice or document to a party hereof in compliance
with Section 9(a) of this Subscription Agreement shall be effective service of process for any action, suit or proceeding
in a Designated Court with respect to any matters to which the parties have submitted to jurisdiction as set forth above.

 

(r)              
This Subscription Agreement may only be enforced against, and any claim, action, suit or other legal proceeding based upon, arising out
of, or related to this Subscription Agreement, or the negotiation, execution or performance of this Subscription Agreement, may only be
brought against the entities that are expressly named as parties hereto and then only with respect to the specific obligations set forth
herein with respect to such party. No past, present or future director, officer, employee, incorporator, manager, member, partner, shareholder,
affiliate, agent, attorney or other representative of any party hereto or of any affiliate of any party hereto, or any of their successors
or permitted assigns, shall have any liability for any obligations or liabilities of any party hereto under this Subscription Agreement
or for any claim, action, suit or other legal proceeding based on, in respect of or by reason of the transactions contemplated hereby.

 

    25

     

    

 

(s)             
The Company shall, by 9:00 a.m., Eastern Time, on or before the fourth Business Day immediately following the date of this
Subscription Agreement, issue one or more press releases or file with the Commission a Current Report on Form 8-K (collectively, the
 “Disclosure Document”) disclosing, to the extent not previously publicly disclosed, all material terms of the
transactions contemplated hereby (and by the Other Subscription Agreements), the Transaction and any other material, nonpublic
information that the Company has provided to Subscriber at any time prior to the filing of the Disclosure Document. Notwithstanding
the foregoing, or anything contained to the contrary in Section 9(c), the Company shall not publicly disclose the name of
Subscriber or any affiliate or investment advisor of Subscriber, or include the name of Subscriber or any affiliate or investment
advisor of Subscriber in any press release or in any filing with the Commission or any regulatory agency or trading market, without
the prior written consent (including by e-mail) of Subscriber, except as required by the federal securities laws, rules or
regulations and to the extent such disclosure is required by other laws, rules or regulations, at the request of the staff of the
Commission or regulatory agency or under NYSE regulations, in which case the Company shall provide Subscriber with reasonable prior
written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with Subscriber regarding such
disclosure. Subscriber hereby consents to the publication and disclosure in any Form 8-K or Form 6-K filed by the Company with the
Commission, in any filing with the Commission made in connection with the Business Combination Agreement and the Transaction,
including any proxy statement, prospectus or registration statement related thereto or any other filing with the Commission pursuant
to applicable securities laws, of Subscriber’s name and identity and the nature of Subscriber’s commitments,
arrangements and understandings under and relating to this Subscription Agreement and, if deemed required or appropriate by the
Company, a copy of this Subscription Agreement. Any such disclosure under the foregoing two sentences shall be made only after the
Company as soon as practicable notifies Subscriber of such requirement to disclose (except where prohibited by applicable law, legal
process or regulatory request). The Company shall provide a draft of any proposed disclosures under this Section 9(s) to
subscriber reasonably in advance of the release of such disclosures, but in no event less than one Business Day prior to release,
and shall consider in good faith any revisions to such disclosure proposed by Subscriber. Notwithstanding the foregoing or anything
contained to the contrary in Section 9(c), the Company may make disclosures to an auditor or governmental or regulatory
authority pursuant to any routine investigation, inspection, examination or inquiry without providing Subscriber with any
notification thereof, unless Subscriber is the subject of any such investigation, inspection, examination or inquiry (in which case
the preceding sentence shall govern).

 

(t)              
The obligations of Subscriber under this Subscription Agreement are several and not joint with the obligations of any Other
Subscriber or any other investor under the Other Subscription Agreements, and Subscriber shall not be responsible in any way for the
performance of the obligations of any Other Subscriber under this Subscription Agreement or any other investor under the Other
Subscription Agreements. The decision of Subscriber to purchase Subscribed Shares and the Private Placement Warrants pursuant to
this Subscription Agreement has been made by Subscriber independently of any Other Subscriber or any other investor and
independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or any of its subsidiaries which
may have been made or given by any Other Subscriber or investor or by any agent or employee of any Other Subscriber or investor, and
neither Subscriber nor any of its agents or employees shall have any liability to any Other Subscriber or investor (or any other
person) relating to or arising from any such information, materials, statements or opinions. Nothing contained herein or in any
Other Subscription Agreement, and no action taken by Subscriber or investor pursuant hereto or thereto, shall be deemed to
constitute Subscriber and other investors as a partnership, an association, a joint venture or any other kind of entity, or create a
presumption that Subscriber and other investors are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated by the this Subscription Agreement and the Other Subscription Agreements. Subscriber acknowledges that
no Other Subscriber has acted as agent for Subscriber in connection with making its investment hereunder and no Other Subscriber
will be acting as agent of Subscriber in connection with monitoring its investment in the Subscribed Shares and the Private
Placement Warrants or enforcing its rights under this Subscription Agreement. Subscriber shall be entitled to independently protect
and enforce its rights, including without limitation the rights arising out of this Subscription Agreement, and it shall not be
necessary for any Other Subscriber or investor to be joined as an additional party in any proceeding for such purpose.

 

[Signature pages follow.]

 

    26

     

    

 

IN WITNESS WHEREOF,
each of the Company and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date first set forth above.

 

	 	JATT ACQUISITION CORP
	 	 	 
	 	By: 	 
	 	 	Name:Someit Sidhu
	 	 	Title:Chief Executive Officer
	 	 	 
	 	Address for Notices:
	 	PO Box 309, Ugland House,
	 	Grand Cayman, Cayman Islands

 

Signature Page to JATT
Acquisition Corp Subscription Agreement

 

     

     

    

 

	SUBSCRIBER:	 
	Signature of Subscriber:	 
	 	 
	By:	                                     	 
	Name:	 
	Title:	 
	Date:	 	 
	Name of Subscriber:	 
	 	 
	 	 
	(Please print. Please indicate name and	 
	capacity of person signing above)	 
	 	 
	 	 
	Name in which shares are to be registered	 
	(if different):	 
	 	 
	Email Address: 	 
	 	 
	 	 
	Subscriber’s EIN: 	 
	 	 
	 	 
	Jurisdiction of residency:                                                        	 
	 	 
	Number of Subscribed Shares subscribed for:
                                                      	 
	 	 
	Price Per Subscribed Share and Private Placement
    Warrant:                     $10.00	 
	 	 
	Subscription Amount:                                   $                       	 

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account of the Company specified by the Company
in the Closing Notice.

 

Signature Page to JATT
Acquisition Corp Subscription Agreement

 

     

     

    

 

EXHIBIT A

 

Private Placement Warrant
Schedule

 

Signature Page to JATT
Acquisition Corp Subscription Agreement

 

     

     

    

 

Annex
A

 

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

This Annex A should be completed and signed by
Subscriber

and constitutes a part of the Subscription Agreement.

 

	A.	QUALIFIED
INSTITUTIONAL BUYER STATUS (Please check the box, if applicable)

 

	 	 ̈	Subscriber is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

	B.	FINRA INSTITUTIONAL INVESTOR STATUS (Please check the box)

 

	 	 ̈	Subscriber is a “institutional investor” (as defined in FINRA Rule 2111).

 

	C.	ACCREDITED INVESTOR STATUS (Please check the box)

 

	 	 ̈	Subscriber is an “accredited
    investor” (within the meaning of Rule 501(a) under the Securities Act) and has marked and initialed the appropriate box below
    indicating the provision under which it qualifies as an “accredited investor.”

 

	D.	NON-U.S. PERSON STATUS (Please check the box)

 

	 	 ̈ 	Subscriber is a non-U.S. person located outside of the United States.

 

	E.	AFFILIATE STATUS
	 	(Please check the applicable box)

 

		SUBSCRIBER:
	 	 ̈ is:
	 	 ̈ is not:
	 	an “affiliate” (as defined
in Rule 144 under the Securities Act) of the Company or acting on behalf of an affiliate of the Company.

 

Rule 501(a), in relevant part,
states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the
issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person.
Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Subscriber and under
which Subscriber accordingly qualifies as an “accredited investor.”

 

	 	 ̈	(1) Any bank, registered broker or dealer, insurance company, registered investment company, private business development company, or small business investment company;
	 	 ̈	(2) Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
	 	 ̈	(3) Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment advisor makes the investment decisions, or if the plan has total assets in excess of $5,000,000;
	 	 ̈	(4) Any corporation, similar business trust, partnership or any organization described in Section 501(c)(3) of the Internal Revenue Code, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;
	 	 ̈	(5) Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or
	 	 ̈	(6) Any entity, of a type not listed in items (1), (2), (3), (4), or (5) herein, not formed for the specific purpose of acquiring the securities offered, owning investments in excess of $5,000,000; or 
	 	 ̈	(7) Any “family office,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940: (i) with assets under management in excess of $5,000,000, (ii) that is not formed for the specific purpose of acquiring the securities offered, and (iii) whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment.

 

    A-1

     

    

 

	F.	FINRA INSTITUTIONAL ACCOUNT STATUS
	 	(Please check the applicable subparagraphs):

 

	 	 ̈   Subscriber is an “institutional account” under FINRA Rule 4512(c).
	 	 
	 	 ̈   Subscriber is not an “institutional account” under FINRA Rule 4512(c).

 

	 	SUBSCRIBER:
	 	Print Name: 
	 	 
	 	By: 
	 	Name:
	 	Title:

 

    A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]